<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006619.pub2" GROUP_ID="ARI" ID="483305090106052364" MERGED_FROM="" MODIFIED="2013-10-02 23:06:18 +0100" MODIFIED_BY="Liz Dooley" NOTES="&lt;p&gt;US grammar&lt;/p&gt;" NOTES_MODIFIED="2013-10-03 08:03:55 +1000" NOTES_MODIFIED_BY="Liz Dooley" REVIEW_NO="A117" REVMAN_SUB_VERSION="5.2.6 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2013-10-02 23:06:18 +0100" MODIFIED_BY="Liz Dooley">
<TITLE>Nebulized epinephrine for croup in children</TITLE>
<CONTACT MODIFIED="2013-10-02 23:06:18 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="6F4F61EF82E26AA20071EDC003B483E1" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Candice</FIRST_NAME><LAST_NAME>Bjornson</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>candice.bjornson@albertahealthservices.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Pediatrics</DEPARTMENT><ORGANISATION>Faculty of Medicine, University of Calgary, Alberta Children's Hospital</ORGANISATION><ADDRESS_1>2888 Shaganappi Trail NW</ADDRESS_1><CITY>Calgary</CITY><ZIP>T3B 6A8</ZIP><REGION>Alberta</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 403 955 2952</PHONE_1><FAX_1>+1 403 955 7059</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-10-02 23:06:18 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="6F4F61EF82E26AA20071EDC003B483E1" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Candice</FIRST_NAME><LAST_NAME>Bjornson</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>candice.bjornson@albertahealthservices.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Pediatrics</DEPARTMENT><ORGANISATION>Faculty of Medicine, University of Calgary, Alberta Children's Hospital</ORGANISATION><ADDRESS_1>2888 Shaganappi Trail NW</ADDRESS_1><CITY>Calgary</CITY><ZIP>T3B 6A8</ZIP><REGION>Alberta</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 403 955 2952</PHONE_1><FAX_1>+1 403 955 7059</FAX_1></ADDRESS></PERSON><PERSON ID="12327" ROLE="AUTHOR"><FIRST_NAME>Kelly</FIRST_NAME><LAST_NAME>Russell</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Assistant Professor</POSITION><EMAIL_1>krussell@mich.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Pediatrics and Child Health</DEPARTMENT><ORGANISATION>University of Manitoba</ORGANISATION><ADDRESS_1>6596-715 McDermot Ave</ADDRESS_1><CITY>Winnipeg</CITY><ZIP>R3E 3P4</ZIP><REGION>Manitoba</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 204 480 1312</PHONE_1><FAX_1>+1 204 789 3915</FAX_1></ADDRESS></PERSON><PERSON ID="19902" ROLE="AUTHOR"><FIRST_NAME>Ben</FIRST_NAME><LAST_NAME>Vandermeer</LAST_NAME><SUFFIX>BSc, MSc</SUFFIX><POSITION>Statistician</POSITION><EMAIL_1>bv1@ualberta.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Pediatrics</DEPARTMENT><ORGANISATION>University of Alberta</ORGANISATION><ADDRESS_1>4-496B Edmonton Clinic Health Academy (ECHA)</ADDRESS_1><ADDRESS_2>11405 - 87 Avenue</ADDRESS_2><CITY>Edmonton</CITY><ZIP>T6G 1C9</ZIP><REGION>Alberta</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 780 492 6355</PHONE_1><FAX_1>+1 780 248 5625</FAX_1></ADDRESS></PERSON><PERSON ID="5344" ROLE="AUTHOR"><FIRST_NAME>Terry</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>Klassen</LAST_NAME><SUFFIX>MD, MSc, FRCPC</SUFFIX><POSITION>Director</POSITION><EMAIL_1>tklassen@mich.ca</EMAIL_1><URL>http://www.mich.ca</URL><MOBILE_PHONE>+1 780 970 3615</MOBILE_PHONE><ADDRESS><ORGANISATION>Manitoba Institute of Child Health</ORGANISATION><ADDRESS_1>513-715 McDermot Avenue</ADDRESS_1><CITY>Winnipeg</CITY><ZIP>MB R3E 3P4</ZIP><REGION>Manitoba</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 204 789 3754</PHONE_1></ADDRESS></PERSON><PERSON ID="12282" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>David</FIRST_NAME><MIDDLE_INITIALS>W</MIDDLE_INITIALS><LAST_NAME>Johnson</LAST_NAME><POSITION>Pediatric Emergency Physician and Medical Toxicologist</POSITION><EMAIL_1>david.johnson@albertahealthservices.ca</EMAIL_1><MOBILE_PHONE>+1 403 473 6442</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Pediatrics</DEPARTMENT><ORGANISATION>Faculty of Medicine, University of Calgary, Alberta Children's Hospital</ORGANISATION><ADDRESS_1>2888 Shaganappi Trail NW</ADDRESS_1><CITY>Calgary</CITY><ZIP>T3B 6A8</ZIP><REGION>Alberta</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 403 955 7507</PHONE_1><FAX_1>+1 403 955 7552</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-07-22 11:56:00 +1000" MODIFIED_BY="Sarah Thorning">
<UP_TO_DATE>
<DATE DAY="3" MONTH="7" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="3" MONTH="7" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="3" MONTH="7" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2011"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2011"/>
</DATES>
<WHATS_NEW MODIFIED="2013-07-22 11:56:07 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-07-22 11:56:07 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>No new trials were included in this update. We excluded seven new trials (<LINK REF="STD-Danen-2011" TYPE="STUDY">Danen 2011</LINK>; <LINK REF="STD-da-Silva-2012" TYPE="STUDY">da Silva 2012</LINK>; <LINK REF="STD-de-Benedictis-2012" TYPE="STUDY">de Benedictis 2012</LINK>; <LINK REF="STD-Frazier-2010" TYPE="STUDY">Frazier 2010</LINK>; <LINK REF="STD-Kline_x002d_Krammes-2012" TYPE="STUDY">Kline-Krammes 2012</LINK>; <LINK REF="STD-Pitluk-2011" TYPE="STUDY">Pitluk 2011</LINK>; <LINK REF="STD-Zoorob-2011" TYPE="STUDY">Zoorob 2011</LINK>) and our conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-07-03 17:04:59 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>Searches conducted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-09-01 10:15:04 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-09-01 10:15:04 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-06-21 08:03:31 +1000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-10-03 08:01:17 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-09-01 10:55:36 +1000" MODIFIED_BY="[Empty name]">Nebulized epinephrine for croup in children</TITLE>
<SUMMARY_BODY MODIFIED="2013-10-03 08:01:17 +1000" MODIFIED_BY="[Empty name]">
<P>Croup is a common childhood illness which primarily affects those between the ages of six months and three years, with a peak annual incidence in the second year of life of nearly five per cent. Males and females are affected equally. Croup is most often caused by a viral infection. Symptoms of croup include a hoarse voice, a 'barking' cough and noisy breathing. These symptoms are the result of swelling that occurs in the area of the windpipe (trachea) just below the voice box (larynx). Although most cases of croup are mild and resolve on their own, occasionally the swelling can be severe enough to cause difficulty in breathing. In these children, epinephrine (also called adrenaline) is a medication that is inhaled as a mist to temporarily shrink the swollen area in the trachea.   </P>
<P>This review looked at trials of inhaled epinephrine for the treatment of children with croup and is comprised of only eight studies with 225 participants. Of the eight included studies, six were assessed as having low risk of bias and two as unclear risk of bias (based upon assessment of adequate random sequence generation, allocations concealment, blinding of participants and personnel, blinding of outcome assessment, completeness of outcome data, and selective reporting). Studies assessed a variety of outcome measures and few studies examined the same outcomes; therefore, most outcomes contained data from a maximum of three studies, and in some cases only single studies.</P>
<P>Compared to no medication, inhaled epinephrine improved croup symptoms in children at 30 minutes following treatment (three studies, 94 children). This treatment effect disappeared two hours after treatment (one study, 20 children). However, children's symptoms did not become worse than prior to treatment. No study measured adverse events.</P>
<P>The evidence is current to July 2013.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-08-26 20:11:13 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-08-26 20:10:56 +1000" MODIFIED_BY="[Empty name]">
<P>Croup is a common childhood illness characterized by barky cough, stridor, hoarseness and respiratory distress. Children with severe croup are at risk for intubation. Nebulized epinephrine may prevent intubation.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-08-26 19:12:35 +1000" MODIFIED_BY="[Empty name]">
<P>To assess the efficacy (measured by croup scores, rate of intubation and health care utilization such as rate of hospitalization) and safety (frequency and severity of side effects) of nebulized epinephrine versus placebo in children with croup, evaluated in an emergency department (ED) or hospital setting.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-08-26 19:12:54 +1000" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL 2013, Issue 6, MEDLINE (1966 to June week 3, 2013), EMBASE (1980 to July 2013), Web of Science (1974 to July 2013), CINAHL (1982 to July 2013) and Scopus (1996 to July 2013).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-08-26 20:11:13 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs) or quasi-RCTs of children with croup evaluated in an ED or admitted to hospital. Comparisons were: nebulized epinephrine versus placebo, racemic nebulized epinephrine versus L-epinephrine (an isomer) and nebulized epinephrine delivered by intermittent positive pressure breathing (IPPB) versus nebulized epinephrine without IPPB. Primary outcome was change in croup score post-treatment. Secondary outcomes were rate and duration of intubation and hospitalization, croup return visit, parental anxiety and side effects.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>Two authors independently identified potentially relevant studies by title and abstract (when available) and examined relevant studies using a priori inclusion criteria, followed by methodological quality assessment. One author extracted data while the second checked accuracy. We use the standard methodological procedures expected by the Cochrane Collaboration.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-07-02 11:35:04 +1000" MODIFIED_BY="[Empty name]">
<P>Eight studies (225 participants) were included. In general, children included in the studies were young (average age less than two years in the majority of included studies). Severity of croup was described as moderate to severe in all included studies. Six studies took place in the inpatient setting, one in the ED and one setting was not specified. Six of the eight studies were deemed to have a low risk of bias and the risk of bias was unclear in the remaining two studies.</P>
<P>Nebulized epinephrine was associated with croup score improvement 30 minutes post-treatment (three RCTs, standardized mean difference (SMD) -0.94; 95% confidence interval (CI) -1.37 to -0.51; I<SUP>2 </SUP>statistic<SUP> </SUP>= 0%). This effect was not significant two and six hours post-treatment. Nebulized epinephrine was associated with significantly shorter hospital stay than placebo (one RCT, MD -32.0 hours; 95% CI -59.1 to -4.9). Comparing racemic and L-epinephrine, no difference in croup score was found after 30 minutes (SMD 0.33; 95% CI -0.42 to 1.08). After two hours, L-epinephrine showed significant reduction compared with racemic epinephrine (one RCT, SMD 0.87; 95% CI 0.09 to 1.65). There was no significant difference in croup score between administration of nebulized epinephrine via IPPB versus nebulization alone at 30 minutes (one RCT, SMD -0.14; 95% CI -1.24 to 0.95) or two hours (SMD -0.72; 95% CI -1.86 to 0.42). None of the studies sought or reported data on adverse effects.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>Nebulized epinephrine is associated with clinically and statistically significant transient reduction of symptoms of croup 30 minutes post-treatment. Evidence does not favor racemic epinephrine or L-epinephrine, or IPPB over simple nebulization. The authors note that data and analyses were limited by the small number of relevant studies and total number of participants and thus most outcomes contained data from very few or even single studies.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-10-02 06:17:06 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>Croup (laryngotracheobronchitis) is a common respiratory illness of childhood, estimated to affect approximately three per cent of children under six years of age annually (<LINK REF="REF-Denny-1983" TYPE="REFERENCE">Denny 1983</LINK>; <LINK REF="REF-Johnson-2003" TYPE="REFERENCE">Johnson 2003</LINK>). The clinical picture is characterized by the abrupt onset of a distinctive barky cough, which may be accompanied by stridor, hoarse voice and respiratory distress. Croup symptoms are often preceded by non-specific symptoms such as cough, rhinorrhea and fever. The most common etiology is a viral infection, predominantly parainfluenza virus (<LINK REF="REF-Marx--1997" TYPE="REFERENCE">Marx 1997</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-08-26 20:13:16 +1000" MODIFIED_BY="[Empty name]">
<P>While most children with croup have mild symptoms (defined as presence of a 'barky cough', no audible stridor at rest and no to mild chest wall indrawing) (<LINK REF="REF-Johnson-2001" TYPE="REFERENCE">Johnson 2001</LINK>; <LINK REF="REF-Johnson-2003" TYPE="REFERENCE">Johnson 2003</LINK>), a small minority have severe symptoms characterized by marked chest wall indrawing, agitation and lethargy (<LINK REF="REF-Johnson-2001" TYPE="REFERENCE">Johnson 2001</LINK>; <LINK REF="REF-Johnson-2003" TYPE="REFERENCE">Johnson 2003</LINK>). These children are at significant risk for intubation. Corticosteroids decrease both the frequency and duration of hospitalization and intubation (<LINK REF="REF-Kairys-1989" TYPE="REFERENCE">Kairys 1989</LINK>; <LINK REF="REF-Russell-2011" TYPE="REFERENCE">Russell 2011</LINK>; <LINK REF="REF-Tibballs-1992" TYPE="REFERENCE">Tibballs 1992</LINK>). A systematic review of corticosteroids found that compared to placebo, corticosteroids significantly reduced six and 12-hour croup scores, reduced length of hospital stay and reduced return visits (<LINK REF="REF-Russell-2011" TYPE="REFERENCE">Russell 2011</LINK>). However, corticosteroids take approximately 30 minutes after treatment to lessen respiratory distress (<LINK REF="REF-Dobrovoljac-2012" TYPE="REFERENCE">Dobrovoljac 2012</LINK>). Consequently in children with the most severe symptoms, a therapy with a rapid rate of onset may lessen the need for intubation. The therapy most commonly used for this purpose is nebulized epinephrine. Children with moderate to severe croup are usually administered both epinephrine and corticosteroids concurrently to reduce respiratory distress while awaiting the effects of the corticosteroid treatment. Alternative therapies are mist and heliox (helium-oxygen mixture) (<LINK REF="REF-Johnson-2005" TYPE="REFERENCE">Johnson 2005</LINK>; <LINK REF="STD-Vorwerk-2010" TYPE="STUDY">Vorwerk 2010</LINK>). However, recent evidence suggests that mist provides no significant clinical benefit (<LINK REF="REF-Moore-2007" TYPE="REFERENCE">Moore 2007</LINK>; <LINK REF="REF-Neto-2002" TYPE="REFERENCE">Neto 2002</LINK>; <LINK REF="REF-Scolnik-2006" TYPE="REFERENCE">Scolnik 2006</LINK>). Heliox has greater promise, but it is more cumbersome to use, and has little evidence of effectiveness (<LINK REF="REF-Johnson-2005" TYPE="REFERENCE">Johnson 2005</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2013-10-02 06:17:06 +1000" MODIFIED_BY="[Empty name]">
<P>Nebulized epinephrine has been widely used for more than 30 years, after the first report of its effectiveness in 1971 (<LINK REF="REF-Adair-1971" TYPE="REFERENCE">Adair 1971</LINK>). It is thought that epinephrine-induced vasoconstriction decreases upper airway edema (<LINK REF="STD-Brown-2002" TYPE="STUDY">Brown 2002</LINK>; <LINK REF="REF-Johnson-2005" TYPE="REFERENCE">Johnson 2005</LINK>; <LINK REF="REF-Kaditis-1998" TYPE="REFERENCE">Kaditis 1998</LINK>; <LINK REF="REF-Klassen-1999" TYPE="REFERENCE">Klassen 1999</LINK>). A small number of randomized controlled trials (RCTs) have been published (<LINK REF="REF-Johnson-2005" TYPE="REFERENCE">Johnson 2005</LINK>), along with one systematic review (<LINK REF="REF-Bjornson-2011" TYPE="REFERENCE">Bjornson 2011</LINK>).</P>
<P>Initial studies published in the 1970s and early 1980s suggested that epinephrine might be more effective when nebulized via IPPB (intermittent positive pressure breathing) than by nebulization alone. The use of IPPB has now fallen out of favor and it is no longer routinely used.</P>
<P>Clinical severity in children with croup can be determined by both direct measures (clinical scores, transcutaneous carbon dioxide concentrations, pulsus paradoxus, impedance plesmography, radiographic measurement of tracheal diameter) and indirect ones (rate and duration of intubation, rate and duration of hospitalization, rate of return to seek medical care for ongoing croup symptoms, sleep lost by parents, parental stress). Several objective techniques have been reported (<LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="REF-Davis-1993" TYPE="REFERENCE">Davis 1993</LINK>; <LINK REF="REF-Fanconi-1990" TYPE="REFERENCE">Fanconi 1990</LINK>; <LINK REF="STD-Steele-1998" TYPE="STUDY">Steele 1998</LINK>), but none are easy to use, nor measure change across the full range of clinical severity. Consequently they have not been routinely used.</P>
<P>The most widely used direct measures of respiratory severity are different types of croup scores (<LINK REF="REF-Bourchier-1984" TYPE="REFERENCE">Bourchier 1984</LINK>; <LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="REF-Downes-1975" TYPE="REFERENCE">Downes 1975</LINK>; <LINK REF="REF-Geelhoed-1995" TYPE="REFERENCE">Geelhoed 1995</LINK>; <LINK REF="REF-Godden-1997" TYPE="REFERENCE">Godden 1997</LINK>; <LINK REF="REF-Husby--1993" TYPE="REFERENCE">Husby 1993</LINK>; <LINK REF="REF-Leipzig-1979" TYPE="REFERENCE">Leipzig 1979</LINK>; <LINK REF="REF-Massicotte-1973" TYPE="REFERENCE">Massicotte 1973</LINK>; <LINK REF="STD-Taussig-1975" TYPE="STUDY">Taussig 1975</LINK>; <LINK REF="REF-von-Muhlendahl-1982" TYPE="REFERENCE">von Muhlendahl 1982</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>). The Westley croup score has been shown to be reliable (<LINK REF="REF-Johnson-1998" TYPE="REFERENCE">Johnson 1998</LINK>; <LINK REF="REF-Klassen-1994" TYPE="REFERENCE">Klassen 1994</LINK>) and, to some extent, valid (<LINK REF="REF-Klassen-1994" TYPE="REFERENCE">Klassen 1994</LINK>; <LINK REF="REF-Klassen-1995" TYPE="REFERENCE">Klassen 1995</LINK>). None of the other croup scores, to our knowledge, have been assessed for either validity or reliability. On one hand, clinical scores are inevitably subjective at least to some degree, and may not represent truly significant clinical change. On the other hand, clinical scores are arguably more sensitive to change, and therefore more likely to detect smaller degrees of improvement.</P>
<P>Indirect measures of severity, such as health care utilization, are thought by many to capture significant clinical change better than clinical scores. Some would argue that if a treatment cannot be shown to reduce health care utilization, it is of no benefit.</P>
<P>We have chosen to assess and report both direct and indirect measures of clinical change, with the intent of allowing the reader to make their own judgement as to the relative merits of the different measures.</P>
</THEORY>
<IMPORTANCE MODIFIED="2013-07-02 11:40:23 +1000" MODIFIED_BY="[Empty name]">
<P>Croup is a common childhood illness and may result in presentation to the emergency department (ED) due to difficulty in breathing. Epinephrine has been used as a treatment option to reduce tracheal swelling for over 30 years. However, currently there is no systematic review examining the efficacy of this intervention.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-08-26 19:26:18 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Primary objective</HEADING>
<P>To assess the efficacy (measured by croup scores, rate of intubation and health care utilization such as rate of hospitalization) and safety (frequency and severity of side effects) of nebulized epinephrine versus placebo in children with croup, evaluated in an ED or hospital setting.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Secondary objectives</HEADING>
<P>To assess the efficacy and severity of side effects of nebulized racemic epinephrine versus nebulized L-epinephrine in children with croup evaluated in an ED or hospital setting and to assess the efficacy and severity of side effects of nebulized epinephrine delivered with intermittent positive pressure breathing (IPPB) versus nebulized epinephrine alone.</P>
</SUBSECTION>
</OBJECTIVES>
<METHODS MODIFIED="2013-08-26 20:17:18 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-08-26 19:26:47 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-06-21 07:32:02 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs) or quasi-RCTs (Q-RCTs) which compared the use of nebulized epinephrine to placebo, nebulized racemic epinephrine versus nebulized L-epinephrine, and nebulized epinephrine delivered with intermittent positive pressure breathing (IPPB) versus nebulized epinephrine alone in children with croup.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-07-02 11:40:39 +1000" MODIFIED_BY="[Empty name]">
<P>Studies included children with a clinical diagnosis of croup (defined as acute onset of a 'barky cough' and stridor) whether evaluated in an ED or admitted to hospital.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-03-15 07:55:24 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Nebulized epinephrine (either racemic or L-epinephrine, or delivered with or without IPPB) versus placebo.</LI>
<LI>Nebulized racemic epinephrine versus L-epinephrine. </LI>
<LI>Nebulized epinephrine delivered by IPPB versus nebulized epinephrine delivered without IPPB.</LI>
</OL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-08-26 19:26:47 +1000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-07-02 11:42:27 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Should add description of the croup score here.&lt;/p&gt;" NOTES_MODIFIED="2013-07-02 11:42:27 +1000" NOTES_MODIFIED_BY="[Empty name]">
<OL>
<LI>Change in clinical croup scores following treatment.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-08-26 19:26:47 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Rate and duration of intubation.</LI>
<LI>Rate and duration of hospitalization.</LI>
<LI>Rate of return to medical care for ongoing croup symptoms.</LI>
<LI>Improvement.</LI>
<LI>Parental anxiety.</LI>
<LI>Side effects such as hypertension.</LI>
<LI>Evidence of myocardial injury or cardiac arrhythmias.</LI>
</OL>
<P>We evaluated all studies that met the above criteria; we used no exclusion criteria.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 6, part of <I>The Cochrane Library</I>,<I> </I>www.thecochranelibrary.com (accessed 3 July 2013), which contains the Cochrane Acute Respiratory Infections Group's Specialized Register, MEDLINE (1966 to June week 3, 2013), EMBASE (1980 to July 2013), Web of Science (1974 to July 2013), CINAHL (1982 to July 2013) and Scopus (1996 to July 2013).</P>
<P>We used the following search terms to search MEDLINE and CENTRAL. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity- and precision-maximizing version (2008 revision) Ovid format (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). We adapted the search strategy to search EMBASE (see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>), CINAHL (see <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>), Web of Science (see <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>) and Scopus (see <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">MEDLINE (Ovid)</HEADING>
<P>1 exp Laryngitis/<BR/>2 (croup or laryngit*).tw.<BR/>3 laryngotracheit*.tw.<BR/>4 (laryngotracheobronchit* or laryngo-tracheo-bronchit*).tw.<BR/>5 (pseudocroup or pseudo-croup).tw.<BR/>6 or/1-5<BR/>7 Epinephrine/<BR/>8 exp Adrenergic Agonists/<BR/>9 exp Adrenal Cortex Hormones/<BR/>10 epinephrin*.tw,nm.<BR/>11 (adrenalin* or l-adrenalin*).tw,nm.<BR/>12 (adrenergic agonist* or adrenergic alpha-agonist* or adrenergic beta-agonist*).tw,nm.<BR/>13 or/7-12<BR/>14 exp "Nebulizers and Vaporizers"/<BR/>15 Aerosols/<BR/>16 respiratory therapy/ or oxygen inhalation therapy/ or respiration, artificial/ or exp positive-pressure respiration/<BR/>17 (inhal* or vapor* or vapour* or atomiz* or atomis* or nebuliz* or nebulis* or spray* or mist* or aerosol*).tw.<BR/>18 (positive-pressure adj3 (breathing or respiration)).tw.<BR/>19 ippb.tw.<BR/>20 or/14-19<BR/>21 6 and 13 and 20</P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-09-01 11:02:17 +1000" MODIFIED_BY="[Empty name]">
<P>We contacted experts in the field of acute respiratory infections to locate additional studies. There were no language or publication restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-08-26 20:17:18 +1000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-07-02 11:44:31 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (CB, KR) independently scanned abstracts from the initial search results to identify trials that broadly met the inclusion criteria. We then reviewed the full-text articles of the selected trials and the same two review authors independently applied the inclusion criteria. We resolved differences by consensus.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-08-26 19:27:53 +1000" MODIFIED_BY="[Empty name]">
<P>We extracted data using a structured form that captures patient status (ED or inpatient, the author's description of their clinical severity), intervention and control characteristics (such as type of drug: racemic versus L-epinephrine), dosage and method of administration (nebulization alone versus nebulized with intermittent positive pressure breathing (IPPB)). In addition, we collected data on the primary and secondary outcome measures if available: change from baseline clinical croup scores; rate and duration of intubation; rate and duration of hospitalization; and occurrence of hypertension, myocardial injury or cardiac arrhythmias. One review author (KR) extracted data and a second review author (CB) checked this for accuracy. If necessary, we extracted data from graphs or directly from the trial authors.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-08-26 20:15:55 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (CB, KR) independently assessed the quality of studies in three ways. We used more than one method since the relative merits of each remain controversial. First, we used the method outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> that focuses on selection, performance, attrition and detection bias (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Second, we classified concealment of allocation as being a high, low or unclear risk of bias (previously referred to as adequate, inadequate or unclear (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>)). Lastly, we classified studies by who sponsored them: pharmaceutical company, other sources or not mentioned (<LINK REF="REF-Cho-1996" TYPE="REFERENCE">Cho 1996</LINK>). We resolved differences by consensus. We compared and reported the results from the three different classification methods.<B> </B>
</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-08-26 19:28:48 +1000" MODIFIED_BY="[Empty name]">
<P>With regard to continuous variables, we calculated the change from baseline measures if change from baseline measures were not reported directly. As needed, we performed variance imputations according to the work of Follmann (<LINK REF="REF-Follman-1992" TYPE="REFERENCE">Follman 1992</LINK>). We anticipated that different clinical croup scores would be reported. If this was the case, we used trial standardized mean differences (SMDs) for pooled estimates. (A treatment effect (difference between treatment means) divided by its measurement variation (for example, a pooled standard deviation) gives a SMD). We also anticipated that croup scores would be assessed at a variety of time periods. Because the treatment effect of epinephrine is rapid, we assessed change in croup score at 30 minutes, two hours and six hours. If a study did not assess change in croup scores at our time points of interest, we used the closest time point (for example, a 15-minute change in croup score as used for the change in croup score at 30 minutes outcome). We expressed duration of intubation and hospitalization as MDs and calculated an overall MD.</P>
<P>For binary data (that is, intubation and hospitalization rates), we calculated risk ratios (RR). If zero events occurred in both groups, we derived risk differences (RD). If we found significant results, we calculated the number needed to treat to benefit (NNTB) or harm (NNTH). We reported the pooled baseline rates using the inverse variance method.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-07-22 12:00:12 +1000" MODIFIED_BY="[Empty name]">
<P>We calculated the change from baseline measures in cases where change from baseline measures were not reported directly (<LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK>; <LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>). </P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-08-26 20:16:45 +1000" MODIFIED_BY="[Empty name]">
<P>Many variance imputations were performed according to the work of <LINK REF="REF-Follman-1992" TYPE="REFERENCE">Follman 1992</LINK>. The variance of a change from baseline measure was derived from the common variance of a single croup score assuming a correlation of 0.5 between pre- and post-treatment scores (<LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>; <LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>). We imputed variances from upper bound P values (<LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>).</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>We assessed heterogeneity quantitatively with the I<SUP>2</SUP> statistic (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>). The I<SUP>2</SUP> statistic indicates the per cent variability due to between-study (or inter-study) variability as opposed to within-study (or intra-study) variability. We considered an I<SUP>2</SUP> statistic greater than 50% to be large.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2010-12-24 03:47:07 +1000" MODIFIED_BY="[Empty name]">
<P>If at least eight studies were found for our primary outcome we tested for publication bias. In addition to funnel plots, we used the rank correlation test (<LINK REF="REF-Begg-1994" TYPE="REFERENCE">Begg 1994</LINK>) and weighted regression (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>) for the detection of publication bias. We performed adjustment for publication bias in the pooled estimates using the trim and fill method. We used more than one method since the relative merits of the methods are not well established.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-07-02 11:51:34 +1000" MODIFIED_BY="[Empty name]">
<P>For the analyses of all outcomes, we used a random-effects model to combine treatment effects regardless of quantified heterogeneity. We considered a fixed-effect model in sensitivity analyses.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-08-26 20:17:18 +1000" MODIFIED_BY="[Empty name]">
<P>We explored heterogeneity between studies using subgroup and sensitivity analyses performed on the primary outcome of the change in clinical croup scores from baseline to 30 minutes and 60 minutes. We considered the following subgroups: quality (that is, the risk of bias, allocation concealment, funding and simple classification of bias (low, moderate or high)) and inpatient versus ED status.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-07-22 12:02:25 +1000" MODIFIED_BY="[Empty name]">
<P>There were not enough studies in any one meta-analysis to perform any meaningful sensitivity analyses.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-10-02 06:17:51 +1000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2013-08-26 20:17:35 +1000" MODIFIED_BY="[Empty name]">
<P>For the 2011 Cochrane Review, the electronic literature search identified 316 unique studies. After assessing the titles and, when available, the abstracts, we identified 50 studies as being potentially relevant. Reviewing the reference lists of the included studies did not identify any additional studies.</P>
<P>The electronic literature search performed in July 2013 identified 23 studies, one of which was a duplicate, leaving 22 unique studies. After assessing the titles and the abstracts for each of these 22 studies, we identified no new relevant studies.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-08-26 20:18:58 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Need to add explanation how studies using different scales were combined.&lt;/p&gt;" NOTES_MODIFIED="2013-08-26 20:18:58 +1000" NOTES_MODIFIED_BY="[Empty name]">
<P>After applying the a priori inclusion criteria, eight of the 50 studies met the inclusion criteria. Three comparisons were examined: nebulized epinephrine versus placebo (<LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="STD-Fernandez-1993" TYPE="STUDY">Fernandez 1993</LINK>; <LINK REF="STD-Gardner-1973" TYPE="STUDY">Gardner 1973</LINK>; <LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>; <LINK REF="STD-Kuusela-1988" TYPE="STUDY">Kuusela 1988</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>), nebulized racemic epinephrine versus L-epinephrine (<LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>) and nebulized epinephrine with IPPB versus nebulized epinephrine without IPPB (<LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK>). All studies were randomized, placebo-controlled trials with the exception of the study comparing nebulized epinephrine with and without IPPB, which was a cross-over RCT. Seven studies were published in English and one in Spanish (<LINK REF="STD-Fernandez-1993" TYPE="STUDY">Fernandez 1993</LINK>). Studies tended to be small, ranging from 14 to 78 total participants per comparison.   </P>
<SUBSECTION>
<HEADING LEVEL="4">Nebulized epinephrine versus placebo</HEADING>
<P>Four studies took place in an inpatient setting, one in an outpatient setting and one did not specify setting. In general, children within the studies were young (average age two years or less in two studies, two to three years in two studies and not specified in two studies). Severity of croup in the majority of enrolled children was judged to be moderate or moderate to severe in all six studies. There was minor variance between studies in the type of epinephrine used (racemic epinephrine in five studies, L-epinephrine in one study) and dose of racemic epinephrine used (0.5 ml of 2.25% racemic epinephrine in three studies, 0.5 mg/kg of 2.25% racemic epinephrine in two studies, and 0.25 ml of 2.25% racemic epinephrine per five kilograms of body weight in one study). Epinephrine was administered via IPPB in two of the six studies. One study (<LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>) used a croup score which has been validated. The Westley 17-point croup score incorporates assessment of level of consciousness (five points), cyanosis (five points), stridor (two points), air entry (two points) and chest wall retractions (three points). The remaining five studies used a variety of non-validated croup scores as outcome measures, with total possible points ranging from six to 12 points.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Nebulized racemic epinephrine versus L-epinephrine  </HEADING>
<P>We identified a single study suitable for inclusion, of 66 children in an inpatient setting (<LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>). Average age was young (11 months) and baseline severity of croup on study admission was moderate. The doses of racemic epinephrine and L-epinephrine were 0.5 ml of 2.25% and 5 ml of 1:1000 dilution, respectively. A non-validated 10-point croup score (inspiratory breath sounds, two points; stridor, two points; cough, two points, retractions/nasal flaring, two points; cyanosis, two points) was utilized as the primary outcome measure.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Nebulized epinephrine with IPPB versus nebulized epinephrine without IPPB</HEADING>
<P>We identified a single study suitable for inclusion, of 14 children in an inpatient setting (<LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK>). Average age was young (1.9 years) and baseline severity of croup on study admission was moderate. The dose of racemic epinephrine used was 0.25 ml of 2.25%. The IPPB pressure used was 15 cm to 17 cm of water and two hours after the first treatment, cross-over to the other group occurred. A modified 16-point croup score based upon the validated Westley croup score (level of consciousness, four points; color, four points; stridor, three points; air entry, two points; and chest wall retractions, three points) was utilized as the primary outcome measure.  <I>   </I>
</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-10-02 06:17:51 +1000" MODIFIED_BY="[Empty name]">
<P>We excluded a total of 50 studies. The exact reason for exclusion is provided in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>In the original review, we assessed methodological quality using the Jadad scale and concealment of allocation. No studies were added to this update. However, the conclusions concerning methodological quality were revised to reflect the 'Risk of bias' tool. We deemed six of the eight studies to have a low risk of bias and the risk of bias was unclear in the remaining two studies (<LINK REF="STD-Fernandez-1993" TYPE="STUDY">Fernandez 1993</LINK>; <LINK REF="STD-Kuusela-1988" TYPE="STUDY">Kuusela 1988</LINK>). Half of the studies were reported to be of low risk of bias due to adequate concealment of allocation (<LINK REF="STD-Fernandez-1993" TYPE="STUDY">Fernandez 1993</LINK>; <LINK REF="STD-Kuusela-1988" TYPE="STUDY">Kuusela 1988</LINK>; <LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>). Only one study reported a funding source (<LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>). The results from the various quality indicators are pictorially displayed in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2013-08-26 19:30:31 +1000" MODIFIED_BY="[Empty name]">
<P>Allocation concealment was adequate in three of the studies (<LINK REF="STD-Fernandez-1993" TYPE="STUDY">Fernandez 1993</LINK>; <LINK REF="STD-Kuusela-1988" TYPE="STUDY">Kuusela 1988</LINK>; <LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>), inadequate in two (<LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>) and unclear in three (<LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK>; <LINK REF="STD-Gardner-1973" TYPE="STUDY">Gardner 1973</LINK>; <LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2009-07-20 07:18:11 +1000" MODIFIED_BY="[Empty name]">
<P>All trials were double-blind. Two studies did not report who was blinded (<LINK REF="STD-Gardner-1973" TYPE="STUDY">Gardner 1973</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>Four studies reported losses to follow-up (<LINK REF="STD-Kuusela-1988" TYPE="STUDY">Kuusela 1988</LINK>; <LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>; <LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>). However, only one study explained the losses to follow-up (<LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2008-12-29 02:53:34 +1000" MODIFIED_BY="[Empty name]">
<P>All but two studies (<LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK>; <LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>) reported a primary outcome (6/8; 75%).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2009-09-01 11:22:29 +1000" MODIFIED_BY="[Empty name]">
<P>Two studies conducted an intention-to-treat (ITT) analysis (<LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Nebulized epinephrine versus placebo</HEADING>
<P>There were six studies (183 participants) that reported data comparing nebulized epinephrine versus placebo. Four (109 participants) of these six studies took place in an inpatient setting, while one (54 participants) took place in an outpatient setting and one (20 participants) did not specify the setting. While six studies were included in this section, no more than three were included in any particular analysis.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Croup score</HEADING>
<P>Since all studies used different systems in their croup scoring, we used standardized mean differences (SMDs) to synthesize the data. Three studies showed that epinephrine had a statistically significant smaller croup score than placebo after 30 minutes (SMD -0.94; 95% confidence interval (CI) -1.37 to -0.51; I<SUP>2 </SUP>statistic = 0%) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). The change in croup score was almost identical for the two studies that looked at inpatients (SMD -0.82; 95% CI -1.47 to -0.17; I<SUP>2 </SUP>statistic = 0%) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) and the one study that looked at outpatients (SMD -1.03; 95% CI -1.60 to -0.46) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Heterogeneity was negligible in these comparisons.</P>
<P>There were also data on croup score after two hours (SMD -0.15; 95% CI -1.03 to 0.73; one study) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) and six hours (SMD -0.60; 95% CI -1.50 to 0.30; two studies; I<SUP>2 </SUP>statistic = 70%) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Neither of these estimates was statistically significant.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Rate and duration of intubation</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Rate and duration of hospitalization</HEADING>
<P>There were two studies that reported length of hospital stay (in hours), one each in the inpatient and outpatient settings. The inpatient study showed children on epinephrine spent a statistically significant smaller amount of time in the hospital than placebo participants in the hospital (MD -32.00; 95% CI -59.14 to -4.86) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>), while the outpatient study had a much smaller and non-significant difference (MD -1.80; 95% CI -4.07 to 0.47) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). We did not combine these two studies as we would not expect similar hospital stays between inpatients and outpatients.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Rate of return to medical care for ongoing croup symptoms</HEADING>
<P>Return visits were reported by one study. However, that study reported no re-admissions in either the epinephrine or the placebo group, thus we computed no statistics.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Improvement</HEADING>
<P>Two studies counted the number of participants that had significant improvement. Improvement was defined in one study as a decrease in the croup score of greater that two or more points (2/10 total points) (<LINK REF="STD-Gardner-1973" TYPE="STUDY">Gardner 1973</LINK>) and in the other study as a decrease in the croup score of greater than two or more points (2/15) (<LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>). The combined risk ratio (RR) did favor epinephrine but it was not statistically significant (RR 1.46; 95% CI 0.82 to 2.60; I<SUP>2 </SUP>statistic = 17%) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). Heterogeneity was moderate.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Parental anxiety</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Side effects such as hypertension</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Evidence of myocardial injury or cardiac arrhythmias</HEADING>
<P>Not reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Nebulized racemic epinephrine versus L-epinephrine</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Croup score</HEADING>
<P>
<LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK> (28 participants) compared nebulized racemic epinephrine versus L-epinephrine in an outpatient setting. There was no significant difference in croup score between the two types of epinephrine after 30 minutes (SMD 0.33; 95% CI -0.42 to 1.08) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>) but after two hours, L-epinephrine showed significant reduction over racemic epinephrine (SMD 0.87; 95% CI 0.09 to 1.65) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>Rate and duration of intubation. The racemic epinephrine group had an intubation rate of 3/16 and the L-epinephrine group had a rate of 0/14, which was a non-significant difference (RD 0.19; 95% CI -0.03 to 0.40) (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">1. Rate and duration of intubation</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Rate of return to medical care for ongoing croup symptoms</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Improvement</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Parental anxiety</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Side effects such as hypertension</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Evidence of myocardial injury or cardiac arrhythmias</HEADING>
<P>Not reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Nebulized epinephrine with intermittent positive pressure breathing (IPPB) versus nebulized epinephrine without IPPB</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Croup score</HEADING>
<P>
<LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK> (14 participants) compared nebulized epinephrine with IPPB versus nebulized epinephrine without IPPB in an inpatient setting. After 30 minutes, there was no significant difference in croup score between the two groups (SMD -0.72; 95% CI -1.86 to 0.42) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>), while at two hours there was a larger, still non-significant difference (SMD -0.14; 95% CI -1.24 to 0.95) (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Rate and duration of intubation</HEADING>
<P>Intubation was reported as an outcome. However, both groups had zero intubations, thus we computed no statistics.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Rate of return to medical care for ongoing croup symptoms</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Improvement</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Parental anxiety</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Side effects such as hypertension</HEADING>
<P>Not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Evidence of myocardial injury or cardiac arrhythmias</HEADING>
<P>Not reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup, sensitivity and publication bias analysis</HEADING>
<P>Since none of our analyses contained more than three studies, no further analysis exploring heterogeneity or publication bias could be conducted.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-08-26 20:26:08 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-08-26 20:23:28 +1000" MODIFIED_BY="[Empty name]">
<P>Nebulized epinephrine has become standard management, especially in North America, for the treatment of moderate and severe croup. Nebulized epinephrine is typically administered to a child with moderate or severe upper airway obstruction in either an emergency department (ED) or inpatient setting. Though widely used in clinical practice, our search identified only six relevant clinical trials comparing nebulized epinephrine to placebo that included a total of 183 participants (<LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="STD-Fernandez-1993" TYPE="STUDY">Fernandez 1993</LINK>; <LINK REF="STD-Gardner-1973" TYPE="STUDY">Gardner 1973</LINK>; <LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>; <LINK REF="STD-Kuusela-1988" TYPE="STUDY">Kuusela 1988</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Nebulized epinephrine versus placebo</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome: croup score</HEADING>
<P>Data from this review have shown that, compared to placebo, nebulized racemic epinephrine effectively improves croup symptoms as measured by clinical croup scores in children 30 minutes following treatment. Three trials assessed croup score at 30 minutes (<LINK REF="STD-Corkey-1981" TYPE="STUDY">Corkey 1981</LINK>; <LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>; <LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>). Although the number of children was small (94 participants), the pooled data indicated a moderate to large reduction in croup score as compared with placebo (<LINK REF="REF-Cohen-1988" TYPE="REFERENCE">Cohen 1988</LINK>). All three trials favored racemic epinephrine over placebo and the magnitude of benefit was similar and consistent between studies and in both inpatient and outpatient settings.   </P>
<P>At 120 minutes following treatment, the mean difference in croup score was similar in both racemic epinephrine and placebo groups in the single, small (20 participants) study (<LINK REF="STD-Westley-1978" TYPE="STUDY">Westley 1978</LINK>). Although the observed clinical benefit of epinephrine had essentially dissipated at 120 minutes, there was no evidence, on average, to suggest that there was an increase or worsening of croup score, as compared to pre-treatment or baseline in the group of children treated with epinephrine.      </P>
<P>Two studies (69 participants) assessed croup score at six hours following treatment in an inpatient setting (<LINK REF="STD-Fernandez-1993" TYPE="STUDY">Fernandez 1993</LINK>; <LINK REF="STD-Kuusela-1988" TYPE="STUDY">Kuusela 1988</LINK>) and found no difference in croup score between the nebulized racemic epinephrine and placebo groups. This is not surprising given the relatively brief duration of action of nebulized epinephrine and is also consistent with the finding of no difference in croup score at the 120-minute assessment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>In a single inpatient study, hospital stay was shorter among those treated with nebulized racemic epinephrine group as compared with placebo (<LINK REF="STD-Kuusela-1988" TYPE="STUDY">Kuusela 1988</LINK>). The mean difference of 32 hours was both statistically and clinically significant. Confidence intervals were wide, however, reflecting the small study size. Also, corticosteroid was administered to eight of 37 participants and the breakdown by treatment group was not provided. This could account for the shorter hospital stay in the epinephrine group. Length of stay in the outpatient setting was assessed in one study and it was similar between epinephrine and placebo groups (<LINK REF="STD-Kristjansson-1994" TYPE="STUDY">Kristjansson 1994</LINK>). Equal proportions of children (52% and 58% in the racemic epinephrine and placebo groups, respectively) received concomitant corticosteroid treatment. No difference in length of stay is consistent with resolution of clinical effect by two hours after treatment.</P>
<P>We chose to report the outcome proportion of patients improved even though we had not pre-specified it as a secondary outcome because one study (Gardner) did not report the actual croup score values, only the proportion of children whose croup score had improved by two or more points versus those which had not.           </P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Racemic epinephrine versus L-epinephrine</HEADING>
<P>A small, methodologically sound study comparing nebulized racemic epinephrine with L-epinephrine in the outpatient setting showed no difference in croup score 30 minutes following treatment (<LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK>). By 120 minutes, there was a statistically significant result showing L-epinephrine to have a longer duration of benefit than racemic epinephrine.  </P>
<P>Racemic epinephrine is composed of equal proportions of D- and L-isomers of epinephrine and was originally used to treat croup because it was hypothesized that racemic epinephrine would cause fewer cardiovascular side effects than L-epinephrine. L-epinephrine is the type of epinephrine routinely used for other indications in medicine in either 1:1000 or 1:10,000 concentrations. <LINK REF="STD-Waisman-1992" TYPE="STUDY">Waisman 1992</LINK> administered an identical 5 mg of L-epinephrine (0.5 ml of 2.25% racemic epinephrine versus 5.0 ml of 1:1000 epinephrine) and found no statistically significant differences in cardiovascular side effects between the two drugs. In addition, it is now known that only L-epinephrine is pharmacologically active; the R-isomer has no activity (<LINK REF="REF-Westfall-2009" TYPE="REFERENCE">Westfall 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Nebulized epinephrine with IPPB versus nebulized epinephrine without IPPB</HEADING>
<P>One study of good methodological quality found that nebulized epinephrine with IPPB was similar to nebulized epinephrine without IPPB in the inpatient setting (<LINK REF="STD-Fogel-1982" TYPE="STUDY">Fogel 1982</LINK>). However, this study was small and not designed to show equivalence. Nonetheless, given the technical challenges of IPPB and no evidence of superiority, routine use of nebulized epinephrine without IPPB seems justified. </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Safety of nebulized epinephrine</HEADING>
<P>Though none of the clinical trials reported significant adverse events associated with nebulized epinephrine, the small total number of participants and rarity of adverse events provides insufficient data to conclude that the use of nebulized epinephrine is universally safe. Further, none of these trials assessed the effectiveness or safety of epinephrine when administered repeatedly in a row. A single case report of ventricular tachycardia and myocardial infarction in a previously healthy child who received three doses of nebulized epinephrine in one hour raises concerns about potential cardiac toxicity (<LINK REF="REF-Butte-1999" TYPE="REFERENCE">Butte 1999</LINK>). While this case is of concern, given the widespread use of epinephrine over several decades, it seems unlikely, however, that one or even two nebulized doses of epinephrine poses significant risk to a child.     </P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-07-02 12:15:04 +1000" MODIFIED_BY="[Empty name]">
<P>The number of relevant studies was small, as were total numbers of participants. Studies assessed a wide range of outcomes and few studies examined the same outcomes, thus most outcomes contained data from very few or even single studies. Timing of outcome measures also varied between studies. Finally, co-interventions (for example, corticosteroid administration) were not explicitly described for some studies. There were too few studies included to formally assess publication bias. </P>
<P>We did not search for articles which included co-treatment with corticosteroids, as the question of whether adjunct epinephrine therapy provides additional benefit to corticosteroid treatment alone will be addressed in a separate Cochrane Review. </P>
<P>Finally, none of the studies included children with mild croup. However, mild croup is defined as minimal to no symptoms of airway obstruction on presentation; epinephrine is used to provide temporary relief of airway obstructive symptoms and, thus, there is not a strong rationale for the use of epinephrine in children with mild croup. </P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>The majority of the studies were at low risk of bias and half of the studies reported adequately concealed patient allocation methods. While all studies were double-blind and the majority of the studies reported their primary outcome, several studies reported a loss to follow-up and few studies conducted an intention-to-treat analysis.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-08-26 20:26:08 +1000" MODIFIED_BY="[Empty name]">
<P>We undertook a broad and extensive search strategy of multiple databases, contacted experts in the field and applied no language or publication restrictions to minimize the chance of bias due to missing published studies or non-English language studies. This review did contain one Spanish language study. As none of our analyses contained more than three studies, no further analysis exploring heterogeneity or publication bias could be performed. Thus, the possibility of publication bias cannot be ruled out. </P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2008-12-21 05:55:36 +1000" MODIFIED_BY="[Empty name]">
<P>We did not identify any other relevant studies or systematic reviews in publication. </P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-12-24 03:58:33 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2010-12-24 03:58:21 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Nebulized epinephrine may be used to treat obstructive airway symptoms associated with moderate to severe croup.     </LI>
<LI>The clinical effect of nebulized epinephrine is apparent at 30 minutes post-treatment.</LI>
<LI>There is no evidence to suggest that croup symptoms, on average, worsen after the treatment effect of nebulized epinephrine dissipates.    </LI>
<LI>Five out of six epinephrine versus placebo trials have used racemic epinephrine. There is only one small, good quality trial comparing racemic epinephrine versus L-epinephrine and it provides reasonable evidence that L-epinephrine is at least as effective as racemic epinephrine if this drug for some reason is not available.</LI>
<LI>The addition of IPPB did not appear to improve the clinical effect of epinephrine as compared with nebulization alone.</LI>
</UL>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-12-24 03:58:33 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Surveillance and reporting of adverse events associated with the administration of nebulized epinephrine should be carried out.</LI>
<LI>Additional studies of interest might focus on health care utilization as an outcome.  </LI>
</UL>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-08-26 20:26:53 +1000" MODIFIED_BY="[Empty name]">
<P>The review authors wish to thank the following people for commenting on the draft protocol: Josephine Wai Leng Chow, Gary Geelhoed, Joe Luria, Max Bulsara and Juan Lozano. We wish to thank the following people for commenting on the draft review: Jiaan-Der Wang, Shweta Bansal, Chris Vorwerk, Aroonwan Preutthipan, Teresa Neeman and<B> </B>Inge Axelsson.</P>
<P>We also thank Alberto Nettel-Aguirre for assessing the Spanish article for inclusion, assessing methodological quality and extracting appropriate data.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-09-11 16:23:05 +1000" MODIFIED_BY="Liz Dooley">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-08-26 20:27:15 +1000" MODIFIED_BY="[Empty name]">
<P>Candice Bjornson (CB) critically reviewed the protocol. She selected articles based on their abstract, reviewed and included articles based on their full text and determined whether the studies met this review's inclusion/exclusion criteria, and checked data extracted from included articles for accuracy and completeness. She also analyzed and interpreted the review's results, and drafted the discussion and conclusions.</P>
<P>Kelly Russell (KR) reviewed and selected articles based on their abstract, reviewed and included articles based on their full text as to whether they meet this review's inclusion/exclusion criteria, and checked data extracted from included articles for accuracy and completeness. She also critically reviewed drafts of the review.</P>
<P>Ben Vandermeer (BV) critically reviewed the protocol, focusing on data analysis. He analyzed and interpreted the review's results. He also critically reviewed drafts of the review.</P>
<P>Terry Klassen (TK) critically reviewed the protocol and critically reviewed drafts of the review.</P>
<P>David Johnson (DJ) conceived the idea of a systematic review on this topic and wrote the protocol. He analyzed and interpreted the review's results and critically reviewed the discussion and conclusions.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2010-12-24 03:59:26 +1000" MODIFIED_BY="[Empty name]">
<P>'Improvement' was measured in several studies, therefore it was added to the secondary outcomes.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-08-26 19:52:57 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Corkey-1981" NAME="Corkey 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corkey C, Barker G, Edmonds J, Mok P, Newth C</AU>
<TI>Radiographic tracheal diameter measurements in acute infectious croup: an objective scoring system</TI>
<SO>Critical Care Medicine</SO>
<YR>1981</YR>
<VL>9</VL>
<PG>587-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez-1993" MODIFIED="2013-08-26 19:30:31 +1000" MODIFIED_BY="[Empty name]" NAME="Fernandez 1993" YEAR="1993">
<REFERENCE MODIFIED="2013-06-21 07:40:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez MA, Gonzalez SE, Etxefarria RI, Urcelay EI, Diez AM, Ciriza WM, et al</AU>
<TI>Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children</TI>
<SO>Anales Espandoles de Pediatria</SO>
<YR>1993</YR>
<VL>38</VL>
<NO>1</NO>
<PG>29-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fogel-1982" MODIFIED="2009-09-01 12:02:30 +1000" MODIFIED_BY="[Empty name]" NAME="Fogel 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-09-01 12:02:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fogel JM, Berg IJ, Gerber MA, Sherter CB</AU>
<TI>Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with intermittent positive pressure breathing</TI>
<SO>Journal of Pediatrics</SO>
<YR>1982</YR>
<VL>101</VL>
<NO>6</NO>
<PG>1028-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gardner-1973" NAME="Gardner 1973" YEAR="1973">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gardner HG, Powell KR, Roden VJ, Cherry JD</AU>
<TI>The evaluation of racemic epinephrine in the treatment of infectious croup</TI>
<SO>Pediatrics</SO>
<YR>1973</YR>
<VL>52</VL>
<NO>1</NO>
<PG>52-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kristjansson-1994" MODIFIED="2010-11-08 10:39:48 +1000" MODIFIED_BY="[Empty name]" NAME="Kristjansson 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-11-08 10:39:48 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kristjansson S, Berg-Kelly K, Winso E</AU>
<TI>Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup. Clinical symptom score and oxygen saturation measurements for evaluation of treatment effects</TI>
<SO>Acta Paediatrica</SO>
<YR>1994</YR>
<VL>83</VL>
<NO>11</NO>
<PG>1156-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuusela-1988" NAME="Kuusela 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuusela AL, Vesikari T</AU>
<TI>A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1988</YR>
<VL>77</VL>
<NO>1</NO>
<PG>99-104</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Waisman-1992" MODIFIED="2009-09-01 10:16:47 +1000" MODIFIED_BY="[Empty name]" NAME="Waisman 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-09-01 10:16:47 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Waisman Y, Klein BL, Boenning DA, Young GM, Chamberlain JM, O'Donnel R, et al</AU>
<TI>Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup)</TI>
<SO>Pediatrics</SO>
<YR>1992</YR>
<VL>89</VL>
<NO>2</NO>
<PG>302-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Westley-1978" MODIFIED="2013-08-26 19:52:57 +1000" MODIFIED_BY="[Empty name]" NAME="Westley 1978" YEAR="1978">
<REFERENCE MODIFIED="2013-08-26 19:52:57 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Westley C, Ross C, Brooks J</AU>
<TI>Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1978</YR>
<VL>132</VL>
<PG>484-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Anonymous-1996" MODIFIED="2013-08-26 19:51:17 +1000" MODIFIED_BY="[Empty name]" NAME="Anonymous 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-08-26 19:51:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>Inhaled budesonide and adrenaline for croup</TI>
<SO>Drug and Therapeutics Bulletin</SO>
<YR>1996</YR>
<VL>34</VL>
<NO>3</NO>
<PG>22-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Banac-2005" MODIFIED="2009-09-01 10:17:16 +1000" MODIFIED_BY="[Empty name]" NAME="Banac 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-09-01 10:17:16 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Banac S, Palcieevski G, Roziemanici V, Ahel V</AU>
<TI>Administration of nebulized L-epinephrine in children with croup</TI>
<SO>Medicina</SO>
<YR>2005</YR>
<VL>41</VL>
<NO>3</NO>
<PG>242-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bass-1978" MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" NAME="Bass 1978" YEAR="1978">
<REFERENCE MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bass JW</AU>
<TI>Croup - IPPB and/or racemic epinephrine therapy</TI>
<SO>Pediatrics</SO>
<YR>1978</YR>
<VL>61</VL>
<NO>1</NO>
<PG>148-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bass-1980" MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" NAME="Bass 1980" YEAR="1980">
<REFERENCE MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bass JW</AU>
<TI>Corticosteroids and racemic epinephrine with IPPB in the treatment of croup</TI>
<SO>Journal of Pediatrics</SO>
<YR>1980</YR>
<VL>96</VL>
<NO>1</NO>
<PG>173-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beaudry-1983" MODIFIED="2009-09-01 10:17:36 +1000" MODIFIED_BY="[Empty name]" NAME="Beaudry 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-09-01 10:17:36 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beaudry PH, Laussig LM, Bureau M</AU>
<TI>Efficacy of racemic epinephrine in croup</TI>
<SO>Journal of Pediatrics</SO>
<YR>1983</YR>
<VL>103</VL>
<NO>4</NO>
<PG>661-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-2002" NAME="Brown 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;1: Br Med Bull. 2002;61:189-202.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown J</AU>
<TI>The management of croup</TI>
<SO>British Medical Bulletin</SO>
<YR>2002</YR>
<VL>61</VL>
<PG>189-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Celis-1978" MODIFIED="2013-06-21 07:40:30 +1000" MODIFIED_BY="[Empty name]" NAME="Celis 1978" YEAR="1978">
<REFERENCE MODIFIED="2013-06-21 07:40:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Celis PA, Frias VJ, Aragon JG, Eternod GJ, Serafin FJ</AU>
<TI>Evaluation of racemic epinephrine with intermittent positive pressure in the treatment of acute infections laryngotracheitis</TI>
<SO>Boletin Medico del Hospital Infantile de Mexico</SO>
<YR>1978</YR>
<VL>35</VL>
<NO>4</NO>
<PG>59-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cherry-1974" MODIFIED="2009-09-01 10:18:14 +1000" MODIFIED_BY="[Empty name]" NAME="Cherry 1974" YEAR="1974">
<REFERENCE MODIFIED="2009-09-01 10:18:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cherry JD, Powell KR, Gardner HG, Roden VJ</AU>
<TI>Letter: Racemic epinephrine in croup</TI>
<SO>Pediatrics</SO>
<YR>1974</YR>
<VL>53</VL>
<NO>2</NO>
<PG>290-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choi-1999" MODIFIED="2009-09-01 10:18:22 +1000" MODIFIED_BY="[Empty name]" NAME="Choi 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-09-01 10:18:22 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choi B, Song K, Shim J, Hong S</AU>
<TI>Prospective randomized study comparing L-epinephrine and budesonide aerosols in the treatment of moderate to severe croup</TI>
<SO>Journal of the Korean Pediatric Society</SO>
<YR>1999</YR>
<VL>42</VL>
<NO>1</NO>
<PG>40-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cressman-1994" MODIFIED="2009-09-01 10:18:29 +1000" MODIFIED_BY="[Empty name]" NAME="Cressman 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-09-01 10:18:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cressman WR, Myer CM</AU>
<TI>Diagnosis and management of croup and epiglottitis</TI>
<SO>Pediatric Clinics of North America</SO>
<YR>1994</YR>
<VL>41</VL>
<NO>2</NO>
<PG>265-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cristaldi-2001" MODIFIED="2013-06-21 07:40:56 +1000" MODIFIED_BY="[Empty name]" NAME="Cristaldi 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-06-21 07:40:56 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cristaldi A, Villani A, Bifano M, Cavaliere GF, Cristaldi S, Turbacci M, et al</AU>
<TO>Osturzione acuta delle alte vie respiratorie</TO>
<SO>Rivista Italiana Di Pediatria</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>4</NO>
<PG>462-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cronin-1996" MODIFIED="2010-12-24 04:09:58 +1000" MODIFIED_BY="[Empty name]" NAME="Cronin 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-12-24 04:09:58 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cronin M, Diedericks R</AU>
<TI>Steroids in the management of croup - nebulized adrenaline is also useful</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>312</VL>
<NO>7029</NO>
<PG>510</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danen-2011" MODIFIED="2013-05-25 06:58:29 +1000" MODIFIED_BY="Candice Bjornson" NAME="Danen 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-05-25 06:56:38 +1000" MODIFIED_BY="Candice Bjornson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danen R, Van Der Wouden H, Bindels P</AU>
<TI>Role of corticosteroids in pseudo-croup</TI>
<SO>Huisarts en Wetenschap</SO>
<YR>2011</YR>
<VL>54</VL>
<NO>4</NO>
<PG>204-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dardick-1974" NAME="Dardick 1974" YEAR="1974">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dardick KR</AU>
<TI>Racemic epinephrine in croup</TI>
<SO>Pediatrics</SO>
<YR>1974</YR>
<VL>53</VL>
<NO>2</NO>
<PG>290</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-da-Silva-2012" MODIFIED="2013-06-21 07:41:03 +1000" MODIFIED_BY="Candice Bjornson" NAME="da Silva 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-06-21 07:41:03 +1000" MODIFIED_BY="Candice Bjornson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>da Silva PSL, Fonseca MCM, Iglesias SBO, Junior EL, de Aguiar VE, do Carvalho WB</AU>
<TI>Nebulized 0.5, 2.5 and 5 ml L-epinephrine for post-extubation stridor in children: a prospective, randomized, double-blind clinical trial</TI>
<SO>Intensive Care Medicine</SO>
<YR>2012</YR>
<VL>38</VL>
<NO>2</NO>
<PG>286-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Benedictis-2012" MODIFIED="2013-05-25 06:48:08 +1000" MODIFIED_BY="Candice Bjornson" NAME="de Benedictis 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-05-25 06:48:05 +1000" MODIFIED_BY="Candice Bjornson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Benedictis FM, Bush A</AU>
<TI>Corticosteroids in respiratory diseases in children</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2012</YR>
<VL>185</VL>
<NO>1</NO>
<PG>12-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunman-2005" MODIFIED="2009-09-01 10:19:02 +1000" MODIFIED_BY="[Empty name]" NAME="Dunman 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-09-01 10:19:02 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunman M, Ozdemir D, Atasever S</AU>
<TI>Nebulised L-epinephrine and steroid combination in the treatment of moderate to severe croup</TI>
<SO>Clinical Drug Investigation</SO>
<YR>2005</YR>
<VL>25</VL>
<NO>3</NO>
<PG>183-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ellis-1974" MODIFIED="2009-09-01 10:19:26 +1000" MODIFIED_BY="[Empty name]" NAME="Ellis 1974" YEAR="1974">
<REFERENCE MODIFIED="2009-09-01 10:19:26 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ellis EF, Taylor JC, Lefkowit MS</AU>
<TI>Racemic epinephrine in croup (continued)</TI>
<SO>Pediatrics</SO>
<YR>1974</YR>
<VL>53</VL>
<NO>2</NO>
<PG>291-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fitzgerald-1996" MODIFIED="2009-09-01 10:19:34 +1000" MODIFIED_BY="[Empty name]" NAME="Fitzgerald 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-09-01 10:19:34 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fitzgerald D, Mellis C, Johnson M, Allen H, Cooper P, Asperen P</AU>
<TI>Nebulized budesonide is as effective as adrenaline in moderately severe croup</TI>
<SO>Pediatrics</SO>
<YR>1996</YR>
<VL>97</VL>
<NO>5</NO>
<PG>722-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fogel-1983" NAME="Fogel 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fogel JM, Berg IJ, Gerber MA, Sherter CB</AU>
<TI>Efficacy in racemic epinephrine in croup - reply</TI>
<SO>Journal of Pediatrics</SO>
<YR>1983</YR>
<VL>103</VL>
<NO>4</NO>
<PG>662</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frazier-2010" MODIFIED="2013-07-02 10:56:32 +1000" MODIFIED_BY="Candice Bjornson" NAME="Frazier 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-07-02 10:56:32 +1000" MODIFIED_BY="Candice Bjornson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frazier MD, Cheifetz IM</AU>
<TI>The role of heliox in paediatric respiratory disease</TI>
<SO>Paediatric Respiratory Reviews</SO>
<YR>2010</YR>
<VL>11</VL>
<NO>1</NO>
<PG>46-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghosh-2001" MODIFIED="2010-11-08 10:41:05 +1000" MODIFIED_BY="[Empty name]" NAME="Ghosh 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-11-08 10:41:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghosh A, Morton R</AU>
<TI>Nebulized epinephrine or corticosteroids in croup</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>2</NO>
<PG>119</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gilligan-2005" MODIFIED="2013-06-21 07:41:21 +1000" MODIFIED_BY="[Empty name]" NAME="Gilligan 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-21 07:41:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gilligan P, Shepherd M, Lumsden G, Law H, Brenchley J, Kitching G, et al</AU>
<TI>SOCRATES 4 (synopsis of Cochrane reviews applicable to emergency services)</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>2</NO>
<PG>126-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzalez-1984" MODIFIED="2009-09-01 10:20:55 +1000" MODIFIED_BY="[Empty name]" NAME="Gonzalez 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-09-01 10:20:55 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez ER, Burke TG</AU>
<TI>Review of the status of intermittent positive pressure breathing therapy</TI>
<SO>Drug Intelligence &amp; Clinical Pharmacy</SO>
<YR>1984</YR>
<VL>18</VL>
<NO>12</NO>
<PG>974-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heisinge-1974" NAME="Heisinge 1974" YEAR="1974">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heisinge DH</AU>
<TI>Epinephrine in croup</TI>
<SO>Pediatrics</SO>
<YR>1974</YR>
<VL>53</VL>
<NO>2</NO>
<PG>290</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones-1996" MODIFIED="2010-12-24 04:10:11 +1000" MODIFIED_BY="[Empty name]" NAME="Jones 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-12-24 04:10:11 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jones JS, Hendricks J</AU>
<TI>Racemic epinephrine in the treatment of laryngotracheitis: can relapse be prevented?</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>1996</YR>
<VL>14</VL>
<NO>1</NO>
<PG>104-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klassen-1997" MODIFIED="2009-09-01 10:21:12 +1000" MODIFIED_BY="[Empty name]" NAME="Klassen 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-09-01 10:21:12 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klassen TP</AU>
<TI>Advances in the treatment of bronchiolitis and laryngitis</TI>
<SO>Pediatric Clinics of North America</SO>
<YR>1997</YR>
<VL>44</VL>
<NO>1</NO>
<PG>249</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kline_x002d_Krammes-2012" MODIFIED="2013-07-22 12:08:05 +1000" MODIFIED_BY="Candice Bjornson" NAME="Kline-Krammes 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-07-22 12:08:05 +1000" MODIFIED_BY="Candice Bjornson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kline-Krammes S, Reed C, Giuliano JS Jr, Schwartz HP, Forbes M, Pope J, et al</AU>
<TI>Heliox in children with croup: a strategy to hasten improvement</TI>
<SO>Air Medical Journal</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>3</NO>
<PG>131-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koren-1983" NAME="Koren 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koren G</AU>
<TI>Efficacy of racemic epinephrine in croup</TI>
<SO>Journal of Pediatrics</SO>
<YR>1983</YR>
<VL>103</VL>
<NO>4</NO>
<PG>661</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kunkel-1996" MODIFIED="2009-09-01 10:21:28 +1000" MODIFIED_BY="[Empty name]" NAME="Kunkel 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-09-01 10:21:28 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kunkle NC, Baker MD</AU>
<TI>Use of racemic epinephrine, dexamethasone, and mist in the outpatient management of croup</TI>
<SO>Pediatric Emergency Care</SO>
<YR>1996</YR>
<VL>12</VL>
<NO>3</NO>
<PG>156-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ledwith-1995" MODIFIED="2010-11-08 10:41:29 +1000" MODIFIED_BY="[Empty name]" NAME="Ledwith 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-11-08 10:41:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ledwith CA, Shea LM, Mauro RD</AU>
<TI>Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>1995</YR>
<VL>25</VL>
<NO>3</NO>
<PG>331-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lenney-1978" MODIFIED="2009-09-01 10:21:42 +1000" MODIFIED_BY="[Empty name]" NAME="Lenney 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-09-01 10:21:42 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lenney W, Milner AD</AU>
<TI>Treatment of acute viral croup</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1978</YR>
<VL>53</VL>
<NO>9</NO>
<PG>704-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loriette-1997" MODIFIED="2013-06-21 07:39:48 +1000" MODIFIED_BY="[Empty name]" NAME="Loriette 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-06-21 07:39:48 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Loriette Y, Poirier V, Labbel A</AU>
<TI>Acute laryngitis</TI>
<TO>Laryngites aiguës</TO>
<SO>Revue Internationale de Pediatrie</SO>
<YR>1997</YR>
<VL>278</VL>
<PG>10-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niggermann-1995" MODIFIED="2009-09-01 10:22:07 +1000" MODIFIED_BY="[Empty name]" NAME="Niggermann 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-09-01 10:22:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Niggerman B, Wahn U</AU>
<TI>Micronephrin, adrenaline medihaler aerosol and the use of nebulized steroids for laryngitis</TI>
<SO>Monatsschrift Kinderheilkunde</SO>
<YR>1995</YR>
<VL>143</VL>
<NO>12</NO>
<PG>1259-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Osmond-2002" MODIFIED="2009-08-15 08:49:09 +1000" MODIFIED_BY="[Empty name]" NAME="Osmond 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-08-15 08:49:09 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osmond M</AU>
<TI>Croup</TI>
<SO>Clinical Evidence</SO>
<YR>2002</YR>
<VL>8</VL>
<PG>319-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-08-15 08:48:18 +1000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pitluk-2011" MODIFIED="2013-05-25 07:01:43 +1000" MODIFIED_BY="Candice Bjornson" NAME="Pitluk 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-05-25 07:01:40 +1000" MODIFIED_BY="Candice Bjornson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pitluk JD, Uman H, Safranek S</AU>
<TI>Clinical inquiries. What's best for croup?</TI>
<SO>Journal of Family Practice</SO>
<YR>2011</YR>
<VL>60</VL>
<NO>11</NO>
<PG>680-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Preutthipan-2005" MODIFIED="2010-12-24 04:10:30 +1000" MODIFIED_BY="[Empty name]" NAME="Preutthipan 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-12-24 04:10:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Preutthipan A, Poomthavorn P, Sumanapisan A, Chinrat B, Thasuntia S, Plitponkarnpim A, et al</AU>
<TI>A prospective, randomized double-blind study in children comparing two doses of nebulized L-epinephrine in postintubation croup</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>2005</YR>
<VL>88</VL>
<NO>4</NO>
<PG>508-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Remington-1986" MODIFIED="2009-09-01 10:22:47 +1000" MODIFIED_BY="[Empty name]" NAME="Remington 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-09-01 10:22:47 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Remington S, Meakin G</AU>
<TI>Nebulized adrenaline 1-1000 in the treatment of croup</TI>
<SO>Anaesthesia</SO>
<YR>1986</YR>
<VL>41</VL>
<NO>9</NO>
<PG>923-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rygnestad-2001" MODIFIED="2009-09-01 10:22:57 +1000" MODIFIED_BY="[Empty name]" NAME="Rygnestad 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-09-01 10:22:57 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rygnestad T, Skogvoll E</AU>
<TI>Treatment of pseudocroup with racemic adrenaline</TI>
<SO>Tidsskrift For Den Norske Laegeforening</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>10</NO>
<PG>1263-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singer-1976" MODIFIED="2010-11-08 10:42:06 +1000" MODIFIED_BY="[Empty name]" NAME="Singer 1976" YEAR="1976">
<REFERENCE MODIFIED="2010-11-08 10:42:06 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singer OP, Wilson WJ</AU>
<TI>Laryngotracheobronchitis - 2 years experience with racemic epinephrine</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>1976</YR>
<VL>115</VL>
<NO>2</NO>
<PG>132-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Skolnik-1989" MODIFIED="2009-09-01 10:23:11 +1000" MODIFIED_BY="[Empty name]" NAME="Skolnik 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-09-01 10:23:11 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Skolnik NS</AU>
<TI>Treatment of croup. A critical review</TI>
<SO>American Journal of Disease of Children</SO>
<YR>1989</YR>
<VL>143</VL>
<NO>9</NO>
<PG>1045-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steele-1998" NAME="Steele 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steele DW, Santucci KA, Wright RO, Natarajan R, McQuillen KK, Jay GD</AU>
<TI>Pulsus paradoxus: an objective measure of severity in croup</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1998</YR>
<VL>157</VL>
<PG>331-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taussig-1975" NAME="Taussig 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taussig L, Castro O, Beaudry P, Fox W, Bureau M</AU>
<TI>Treatment of laryngotracheobronchitis (croup): use of intermittent positive-pressure breathing and racemic epinephrine</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1975</YR>
<VL>129</VL>
<PG>790-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taussig-1976" MODIFIED="2010-12-24 04:10:47 +1000" MODIFIED_BY="[Empty name]" NAME="Taussig 1976" YEAR="1976">
<REFERENCE MODIFIED="2010-12-24 04:10:47 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taussig LM</AU>
<TI>Treatment of croup - reply</TI>
<SO>American Journal of Disease of Children</SO>
<YR>1976</YR>
<VL>130</VL>
<NO>3</NO>
<PG>336-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thomas-1998" MODIFIED="2010-11-08 10:42:59 +1000" MODIFIED_BY="[Empty name]" NAME="Thomas 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-11-08 10:42:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thomas LP, Friedland LR</AU>
<TI>The cost-effective use of nebulized racemic epinephrine in the treatment of croup</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>1998</YR>
<VL>16</VL>
<NO>1</NO>
<PG>87-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thompson-1974" NAME="Thompson 1974" YEAR="1974">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thompson RS</AU>
<TI>Racemic epinephrine in croup</TI>
<SO>Pediatrics</SO>
<YR>1974</YR>
<VL>53</VL>
<NO>2</NO>
<PG>292</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vorwerk-2010" MODIFIED="2013-07-02 11:21:24 +1000" MODIFIED_BY="Candice Bjornson" NAME="Vorwerk 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-07-02 11:21:24 +1000" MODIFIED_BY="Candice Bjornson" PRIMARY="NO" TYPE="COCHRANE_REVIEW">
<AU>Vorwerk C, Coats T</AU>
<TI>Heliox for croup in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2013-06-20 05:10:06 +1000" MODIFIED_BY="Candice Bjornson">
<IDENTIFIER MODIFIED="2013-06-20 05:10:06 +1000" MODIFIED_BY="Candice Bjornson" TYPE="DOI" VALUE="10.1002/14651858.CD006822.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weber-2001" MODIFIED="2010-12-24 04:11:55 +1000" MODIFIED_BY="[Empty name]" NAME="Weber 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-12-24 04:11:55 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weber JE, Chudnofsky CR, Younger JG, Larkin GL, Boczar M, Wilkerson MD, et al</AU>
<TI>A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>6</NO>
<PG>E96</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zach-1981" MODIFIED="2010-11-08 10:43:33 +1000" MODIFIED_BY="[Empty name]" NAME="Zach 1981" YEAR="1981">
<REFERENCE MODIFIED="2010-11-08 10:43:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zach M</AU>
<TI>Simple nebulization of racemic epinephrine in the treatment of acute laryngitis (croup)</TI>
<SO>Monatsschrift Kinderheilkunde</SO>
<YR>1981</YR>
<VL>129</VL>
<NO>3</NO>
<PG>168-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zoorob-2011" MODIFIED="2013-05-25 07:03:25 +1000" MODIFIED_BY="Candice Bjornson" NAME="Zoorob 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-05-25 07:03:22 +1000" MODIFIED_BY="Candice Bjornson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zoorob R, Sidani M, Murray J</AU>
<TI>Croup: an overview</TI>
<SO>American Family Physician</SO>
<YR>2011</YR>
<VL>83</VL>
<NO>9</NO>
<PG>1067-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-08-26 20:00:34 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-08-26 20:00:34 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Adair-1971" NAME="Adair 1971" NOTES="&lt;p&gt;Ten-year experience with IPPB in the treatment of acute laryngotracheobronchitis.&lt;br&gt;Anesth Analg. 1971 Jul-Aug;50(4):649-55. No abstract available. &lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Adair J, Ring W, Jordan W, Elwyn R</AU>
<TI>Ten-year experience with IPPB in the treatment of acute laryngotracheobronchitis</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1971</YR>
<VL>50</VL>
<NO>4</NO>
<PG>649-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Begg-1994" NAME="Begg 1994" NOTES="&lt;p&gt;1: Biometrics. 1994 Dec;50(4):1088-101.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Begg CB, Mazumdar M</AU>
<TI>Operating characteristics of a rank correlation test for publication bias</TI>
<SO>Biometrics</SO>
<YR>1994</YR>
<VL>50</VL>
<NO>4</NO>
<PG>1088-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bourchier-1984" MODIFIED="2010-12-24 04:42:41 +1000" MODIFIED_BY="[Empty name]" NAME="Bourchier 1984" TYPE="JOURNAL_ARTICLE">
<AU>Bourchier D, Dawson K, Fergusson D</AU>
<TI>Humidification in viral croup: a controlled trial</TI>
<SO>Australian Paediatric Journal</SO>
<YR>1984</YR>
<VL>20</VL>
<PG>289-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Butte-1999" MODIFIED="2009-09-01 10:25:02 +1000" MODIFIED_BY="[Empty name]" NAME="Butte 1999" TYPE="JOURNAL_ARTICLE">
<AU>Butte M, Nguyen B, Hutchison T, Wiggins J, Ziegler J</AU>
<TI>Pediatric myocardial infarction after racemic epinephrine administration</TI>
<SO>Journal of Pediatrics</SO>
<YR>1999</YR>
<VL>104</VL>
<PG>e9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cho-1996" NAME="Cho 1996" NOTES="&lt;p&gt;Ann Intern Med. 1996 Mar 1;124(5):485-9.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Cho MK, Bero LA</AU>
<TI>The quality of drug studies published in symposium proceedings</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1996</YR>
<VL>124</VL>
<NO>5</NO>
<PG>485-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1988" MODIFIED="2013-07-02 11:03:56 +1000" MODIFIED_BY="[Empty name]" NAME="Cohen 1988" TYPE="BOOK">
<AU>Cohen J</AU>
<SO>Statistical Power Analysis for the Behavioral Science</SO>
<YR>1988</YR>
<EN>2nd</EN>
<PB>Academic Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davis-1993" MODIFIED="2013-07-02 11:22:46 +1000" MODIFIED_BY="Candice Bjornson" NAME="Davis 1993" TYPE="JOURNAL_ARTICLE">
<AU>Davis, Cooper D, Mitchell I</AU>
<TI>The measurement of thoraco-abdominal asynchrony in infants with severe laryngotracheobronchitis</TI>
<SO>Chest</SO>
<YR>1993</YR>
<VL>103</VL>
<PG>1842-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Denny-1983" NAME="Denny 1983" NOTES="&lt;p&gt;Croup: an 11-year study in a pediatric practice.&lt;br&gt;Pediatrics. 1983 Jun;71(6):871-6. &lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Denny F, Murphy T, Clyde W, Collier A, Henderson F</AU>
<TI>Croup: an 11-year study in a pediatric practice</TI>
<SO>Pediatrics</SO>
<YR>1983</YR>
<VL>71</VL>
<NO>6</NO>
<PG>871-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dobrovoljac-2012" MODIFIED="2013-08-02 11:44:25 +1000" MODIFIED_BY="Candice Bjornson" NAME="Dobrovoljac 2012" TYPE="JOURNAL_ARTICLE">
<AU>Dobrovoljac M, Geelhoed GC</AU>
<TI>How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial</TI>
<SO>Emergency Medicine Australasia</SO>
<YR>2012</YR>
<VL>24</VL>
<NO>1</NO>
<PG>79-85</PG>
<IDENTIFIERS MODIFIED="2013-08-02 11:44:25 +1000" MODIFIED_BY="Candice Bjornson">
<IDENTIFIER MODIFIED="2013-08-02 11:44:25 +1000" MODIFIED_BY="Candice Bjornson" TYPE="DOI" VALUE="10.1111/j.1742-6723.2011.01475.x. Epub 2011 Sep 4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Downes-1975" NAME="Downes 1975" TYPE="JOURNAL_ARTICLE">
<AU>Downes J, Raphael R</AU>
<TI>Pediatric intensive care</TI>
<SO>Anesthesiology</SO>
<YR>1975</YR>
<VL>43</VL>
<PG>238-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2010-12-24 04:12:12 +1000" MODIFIED_BY="[Empty name]" NAME="Egger 1997" NOTES="&lt;p&gt;1: BMJ. 1997 Sep 13;315(7109):629-34&lt;/p&gt;" NOTES_MODIFIED="2010-12-24 04:12:12 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fanconi-1990" NAME="Fanconi 1990" TYPE="JOURNAL_ARTICLE">
<AU>Fanconi S, Burger R, Maurer H, Uehlinger J, Ghelfi D, Muhlemann C</AU>
<TI>Transcutaneous carbon dioxide pressure for monitoring patients with severe croup</TI>
<SO>Journal of Pediatrics</SO>
<YR>1990</YR>
<VL>117</VL>
<PG>701-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Follman-1992" NAME="Follman 1992" NOTES="&lt;p&gt;Variance imputation for overviews of clinical trials with continuous response.&lt;br&gt;J Clin Epidemiol. 1992 Jul;45(7):769-73. &lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Follmann D, Elliott P, Suh I, Cutler J</AU>
<TI>Variance imputation for overviews of clinical trials with continuous response</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1992</YR>
<VL>45</VL>
<NO>7</NO>
<PG>769-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Geelhoed-1995" NAME="Geelhoed 1995" TYPE="JOURNAL_ARTICLE">
<AU>Geelhoed G, Macdonald W</AU>
<TI>Oral and inhaled steroids in croup: a randomized placebo-controlled trial</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1995</YR>
<VL>20</VL>
<PG>355-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Godden-1997" MODIFIED="2010-11-08 10:44:14 +1000" MODIFIED_BY="[Empty name]" NAME="Godden 1997" TYPE="JOURNAL_ARTICLE">
<AU>Godden CW, Campbel MJ, Hussey M, Cogswell JJ</AU>
<TI>Double-blind placebo controlled trial of nebulised budesonide for croup</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1997</YR>
<VL>76</VL>
<PG>155-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" NAME="Higgins 2002" NOTES="&lt;p&gt;Quantifying heterogeneity in a meta-analysis.&lt;br&gt;Stat Med. 2002 Jun 15;21(11):1539-58. &lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-07-02 11:04:30 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" NOTES="&lt;p&gt;Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley &amp;amp; Sons, Ltd.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-07-02 11:04:30 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Husby--1993" MODIFIED="2010-12-24 04:13:14 +1000" MODIFIED_BY="[Empty name]" NAME="Husby  1993" TYPE="JOURNAL_ARTICLE">
<AU>Husby S, Agertoft L, Mortensen S, Pedersen D</AU>
<TI>Treatment of croup with nebulised steroid (budesonide): a double blind, placebo-controlled study</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1993</YR>
<VL>68</VL>
<PG>352-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-1998" NAME="Johnson 1998" NOTES="&lt;p&gt;1: N Engl J Med. 1998 Aug 20;339(8):498-503&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D, Jacobson S, Edney P, Hadfield P, Mundy M, Schuh S</AU>
<TI>A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup</TI>
<SO>New England Journal of Medicine</SO>
<YR>1998</YR>
<VL>339</VL>
<NO>8</NO>
<PG>498-503</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2001" MODIFIED="2010-12-24 04:13:28 +1000" MODIFIED_BY="[Empty name]" NAME="Johnson 2001" NOTES="&lt;p&gt;Johnson D, Williamson J. &amp;#8220;Croup: Duration of symptoms and impact on&lt;br&gt;family functioning&amp;#8221; Poster Presentation. Pediatr Research 2001; 49: 83A&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2010-12-24 04:13:28 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D, Williamson J</AU>
<TI>Croup: duration of symptoms and impact on family functioning. Poster presentation</TI>
<SO>Pediatric Research</SO>
<YR>2001</YR>
<VL>49</VL>
<PG>83A</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2003" MODIFIED="2010-11-08 10:44:39 +1000" MODIFIED_BY="[Empty name]" NAME="Johnson 2003" NOTES="&lt;p&gt;Johnson D, Williamson. Health care utilization by children with croup&lt;br&gt;in Alberta. Pediatr Research 2003;53:110A&lt;/p&gt;" NOTES_MODIFIED="2010-11-08 10:44:39 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D, Williamson J</AU>
<TI>Health care utilization by children with croup in Alberta</TI>
<SO>Pediatric Research</SO>
<YR>2003</YR>
<VL>53</VL>
<PG>110A</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2005" NAME="Johnson 2005" NOTES="&lt;p&gt;Croup.&lt;br&gt;Clin Evid. 2005 Dec;(14):310-27. Review. No abstract available.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D</AU>
<TI>Croup</TI>
<SO>Clinical Evidence</SO>
<YR>2005</YR>
<VL>14</VL>
<PG>310-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kaditis-1998" MODIFIED="2010-11-08 10:45:00 +1000" MODIFIED_BY="[Empty name]" NAME="Kaditis 1998" NOTES="&lt;p&gt;1: Pediatr Infect Dis J. 1998 Sep;17(9):827-34&lt;/p&gt;" NOTES_MODIFIED="2010-11-08 10:45:00 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Kaditis A, Wald E</AU>
<TI>Viral croup: current diagnosis and treatment</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>9</NO>
<PG>827-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kairys-1989" NAME="Kairys 1989" NOTES="&lt;p&gt;1: Pediatrics. 1989 May;83(5):683-93&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Kairys S, Olmstead EM, O'Connor G</AU>
<TI>Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials</TI>
<SO>Pediatrics</SO>
<YR>1989</YR>
<VL>83</VL>
<NO>5</NO>
<PG>683-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Klassen-1994" NAME="Klassen 1994" TYPE="JOURNAL_ARTICLE">
<AU>Klassen T, Feldman M, Watters L, Sutcliffe T, Rowe P</AU>
<TI>Nebulized budesonide for children with mild-to-moderate croup</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>331</VL>
<PG>285-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Klassen-1995" MODIFIED="2013-06-21 07:59:42 +1000" MODIFIED_BY="Candice Bjornson" NAME="Klassen 1995" TYPE="JOURNAL_ARTICLE">
<AU>Klassen T, Rowe P</AU>
<TI>The croup score as an evaluative instrument in clinical trials [abstract]</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>1995</YR>
<VL>149</VL>
<PG>60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Klassen-1999" NAME="Klassen 1999" NOTES="&lt;p&gt;Croup. A current perspective.&lt;br&gt;Pediatr Clin North Am. 1999 Dec;46(6):1167-78. Review&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Klassen T</AU>
<TI>Croup: a current perspective</TI>
<SO>Pediatric Clinics of North America</SO>
<YR>1999</YR>
<VL>46</VL>
<NO>6</NO>
<PG>1167-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2013-07-02 11:05:14 +1000" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="BOOK_SECTION">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<ED>Higgins JPT, Green S</ED>
<PB>Wiley-Blackwell</PB>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leipzig-1979" MODIFIED="2010-11-08 10:45:30 +1000" MODIFIED_BY="[Empty name]" NAME="Leipzig 1979" TYPE="JOURNAL_ARTICLE">
<AU>Leipzig B, Oski F, Cummings C, Stockman J, Swender P</AU>
<TI>A prospective randomized study to determine the efficacy of steroids in treatment of croup</TI>
<SO>Journal of Pediatrics</SO>
<YR>1979</YR>
<VL>94</VL>
<PG>194-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marx--1997" MODIFIED="2010-11-08 11:08:51 +1000" MODIFIED_BY="[Empty name]" NAME="Marx  1997" TYPE="JOURNAL_ARTICLE">
<AU>Marx A, Torok TJ, Holman RC, Clarke MJ, Anderson LJ</AU>
<TI>Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1997</YR>
<VL>176</VL>
<NO>6</NO>
<PG>1423-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Massicotte-1973" MODIFIED="2013-08-26 20:00:34 +1000" MODIFIED_BY="Candice Bjornson" NAME="Massicotte 1973" TYPE="JOURNAL_ARTICLE">
<AU>Massicotte P, Tetreault L</AU>
<TI>Evaluation of methyl-prednisolone in the treatment of acute laryngitis in children</TI>
<TO>Evaluation de la methyl-prednisolone dans le traitement des laryngites aigues de l'enfant.</TO>
<SO>L'union Medicale du Canada</SO>
<YR>1973</YR>
<VL>102</VL>
<PG>2064-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moore-2007" MODIFIED="2013-07-22 12:12:33 +1000" MODIFIED_BY="Liz Dooley" NAME="Moore 2007" TYPE="JOURNAL_ARTICLE">
<AU>Moore M, Little P</AU>
<TI>Humidified air inhalation for treating croup</TI>
<SO>Family Practice</SO>
<YR>2007</YR>
<VL>24</VL>
<NO>4</NO>
<PG>295-301</PG>
<IDENTIFIERS MODIFIED="2013-07-22 12:12:33 +1000" MODIFIED_BY="Liz Dooley"/>
</REFERENCE>
<REFERENCE ID="REF-Neto-2002" NAME="Neto 2002" NOTES="&lt;p&gt;Neto GM, Kentab O, Klassen TP, Osmond MH. A randomized controlled&lt;br&gt;trial of mist in the acute treatment of moderate croup. Acad Emerg Med&lt;br&gt;2002;9(9):873-9.&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Neto G, Kentab O, Klassen T, Osmond M</AU>
<TI>A randomized controlled trial of mist in the acute treatment of moderate croup</TI>
<SO>Academic Emergency Medicine</SO>
<YR>2002</YR>
<VL>9</VL>
<NO>9</NO>
<PG>873-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Russell-2011" MODIFIED="2013-07-02 11:10:18 +1000" MODIFIED_BY="Liz Dooley" NAME="Russell 2011" TYPE="COCHRANE_REVIEW">
<AU>Russell KF, Liang Y, O'Gorman K, Johnson DW, Klassen TP</AU>
<TI>Glucocorticoids for croup</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-05-25 07:44:37 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2013-05-25 07:44:37 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD001955.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" MODIFIED="2010-12-24 04:14:45 +1000" MODIFIED_BY="[Empty name]" NAME="Schulz 1995" NOTES="&lt;p&gt;1995 Feb 1;273(5):408-12&lt;/p&gt;" NOTES_MODIFIED="2010-12-24 04:14:45 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scolnik-2006" MODIFIED="2010-12-24 04:14:56 +1000" MODIFIED_BY="[Empty name]" NAME="Scolnik 2006" NOTES="&lt;p&gt;2006 Mar 15;295(11):1274-80&lt;/p&gt;" NOTES_MODIFIED="2010-12-24 04:14:56 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Scolnik D, Coates AL, Stephens D, Da Silva Z, Lavine E, Schuh S</AU>
<TI>Controlled delivery of high vs low humidity vs mist therapy for croup in emergency departments: a randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2006</YR>
<VL>295</VL>
<NO>11</NO>
<PG>1274-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tibballs-1992" NAME="Tibballs 1992" NOTES="&lt;p&gt;1992 Sep 26;340(8822):745-8&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Tibballs J, Shann F, Landau L</AU>
<TI>Placebo-controlled trial of prednisolone in children intubated with croup</TI>
<SO>Lancet</SO>
<YR>1992</YR>
<VL>340</VL>
<NO>8822</NO>
<PG>745-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-von-Muhlendahl-1982" MODIFIED="2009-09-01 10:28:01 +1000" MODIFIED_BY="[Empty name]" NAME="von Muhlendahl 1982" TYPE="JOURNAL_ARTICLE">
<AU>von Muhlendahl K, Kahn D, Spohr H, Dressler F</AU>
<TI>Steroid treatment of pseudo-croup</TI>
<SO>Helvetica Paediatrica Acta</SO>
<YR>1982</YR>
<VL>37</VL>
<PG>431-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Westfall-2009" MODIFIED="2010-12-24 04:15:48 +1000" MODIFIED_BY="[Empty name]" NAME="Westfall 2009" TYPE="BOOK_SECTION">
<AU>Westfall TC, Westfall DP, Brunton LL, Lazo JS, Parker KL</AU>
<TI>Chapter 10. Adrenergic agonists and antagonists</TI>
<SO>The Pharmacological Basis of Therapeutics</SO>
<YR>2009</YR>
<ED>Goodman &amp; Gilman</ED>
<PB>McGraw Hill Companies</PB>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-07-02 11:22:01 +1000" MODIFIED_BY="Candice Bjornson">
<REFERENCE ID="REF-Bjornson-2011" MODIFIED="2013-07-02 11:22:01 +1000" MODIFIED_BY="Candice Bjornson" NAME="Bjornson 2011" TYPE="COCHRANE_REVIEW">
<AU>Bjornson C, Russell KF, Vandermeer B, Durec T, Klassen TP, Johnson DW</AU>
<TI>Nebulized epinephrine for croup in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2013-06-20 06:02:41 +1000" MODIFIED_BY="Candice Bjornson">
<IDENTIFIER MODIFIED="2013-06-20 06:02:41 +1000" MODIFIED_BY="Candice Bjornson" TYPE="DOI" VALUE="10.1002/14651858.CD006619.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-08-26 19:45:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Corkey-1981">
<CHAR_METHODS MODIFIED="2010-03-15 08:49:55 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial. No withdrawals</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-26 19:45:09 +1000" MODIFIED_BY="[Empty name]">
<P>14 children hospitalized with acute infectious croup (spasmodic croup was excluded). No child received either antibiotics or steroid therapy prior to randomization<BR/>Definition of croup: upper respiratory tract infections, often with fever, followed by the onset of inspiratory stridor and barking cough in 24 to 72 hours</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-24 03:28:57 +1000" MODIFIED_BY="[Empty name]">
<P>0.5 mL of 2.25% of racemic epinephrine (containing 5 mg L-epinephrine) with 3.5 mL of distilled water IPPB (n = 8) or 4 mL of placebo with IPPB (n = 6)<BR/>The IPPB flow rate was 10 L/min, 100% oxygen<BR/>Treatment was repeated if clinical score did not improve after 15 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-12-24 03:59:50 +1000" MODIFIED_BY="[Empty name]">
<P>Croup score (6-point score: stridor 1 to 3 points and recession 1 to 3 points) at post-treatment (15 or 30 minutes)<BR/>Change in tracheal diameter</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-03-16 09:55:07 +1000" MODIFIED_BY="[Empty name]">
<P>IPPB: intermittent positive pressure breathing</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-26 19:46:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fernandez-1993">
<CHAR_METHODS MODIFIED="2010-12-24 04:01:00 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial<BR/>No withdrawals</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-26 19:46:03 +1000" MODIFIED_BY="[Empty name]">
<P>All participants (children) hospitalized because of croup symptoms (unclear if spasmodic croup was excluded)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-24 04:01:07 +1000" MODIFIED_BY="[Empty name]">
<P>0.5 mg/kg of nebulized L-epinephrine (containing 5 mg L-epinephrine) (n = 15) or placebo (n = 17) (delivered via nebulization alone)</P>
<P>At least half of the children received IM dexamethasone but it is unclear which treatment they received first<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-12-24 04:01:12 +1000" MODIFIED_BY="[Empty name]">
<P>Croup score (8 points: stridor 0 to 2 points, respiratory distress 0 to 2 points, cough 0 to 2 points, cyanosis 0 to 2 points) at baseline, 6, 12, 18 and 24 hours</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-12-24 04:01:20 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fogel-1982">
<CHAR_METHODS MODIFIED="2013-08-26 19:47:06 +1000" MODIFIED_BY="[Empty name]">
<P>Cross-over, randomized controlled trial<BR/>No withdrawals<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-12-24 04:01:50 +1000" MODIFIED_BY="[Empty name]">
<P>14 children admitted to hospital with persistent inspiratory stridor at rest after 20 to 30 minutes of mist therapy. Children remained in a mist tent during the study period and received supplemental oxygen as indicated<BR/>Definition of croup: inspiratory stridor at rest (unclear if spasmodic croup was excluded)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<P>0.25 mL of 2.25% racemic nebulized epinephrine diluted to 1:8 with isotonic saline (n = 5) or the same dose of nebulized racemic epinephrine with IPPB (n = 9)<BR/>IPPB pressure was 15 to 17 cm<BR/>2 hours after first treatment, children were then crossed over to the other treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-12-24 04:02:11 +1000" MODIFIED_BY="[Empty name]">
<P>Modified Westley croup score (16 points: level of consciousness 0 to 4 points, color 0 to 4 points, stridor 0 to 3 points, air entry 0 to 2 points, retractions 0 to 3 points) at 30, 60, 90 and 120 minutes<BR/>Heart rate<BR/>Respiratory rate<BR/>Supplemental oxygen<BR/>Intubation<BR/>Adverse reactions</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-12-24 04:02:16 +1000" MODIFIED_BY="[Empty name]">
<P>IPPB: intermittent positive pressure breathing</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-12-24 04:03:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gardner-1973">
<CHAR_METHODS MODIFIED="2010-12-24 04:02:22 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial. No withdrawals<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-12-24 04:02:32 +1000" MODIFIED_BY="[Empty name]">
<P>20 children with moderate croup (unclear if spasmodic croup was excluded) - inpatient or outpatient status not reported<BR/>Co-interventions were not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-24 03:29:05 +1000" MODIFIED_BY="[Empty name]">
<P>0.5 mL of 2.25% racemic epinephrine (containing 5 mg L-epinephrine) in 3.5 mL of saline (n = 10) or 4.0 mL of saline (n = 10) (delivered via nebulization alone)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-06 07:40:00 +1000" MODIFIED_BY="[Empty name]">
<P>Croup score (10 points: cough score 0 to 2 points, anxiety/air hunger 0 to 2 points, stridor 0 to 2 points, retractions 0 to 2 points, cyanosis 0 to 2 points); timing of croup score assessment not reported<BR/>Improvement<BR/>Additional treatment of study drug</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-12-24 04:03:04 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-26 19:48:54 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kristjansson-1994">
<CHAR_METHODS MODIFIED="2010-03-15 08:52:34 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial. No withdrawals</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-26 19:48:54 +1000" MODIFIED_BY="[Empty name]">
<P>54 children presenting to the ED with moderate croup (unclear if spasmodic croup was excluded). No co-interventions were given prior to randomization</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-24 03:29:09 +1000" MODIFIED_BY="[Empty name]">
<P>0.5 mg/kg of 2.25% racemic epinephrine (containing 0.25 mg/kg of L-epinephrine) diluted with 0.9% saline solution up to 2 mL (n = 25) or placebo (n = 29) (delivered via nebulization alone)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-06 07:41:01 +1000" MODIFIED_BY="[Empty name]">
<P>Croup score (15 points: inspiratory stridor 0 to 3 points, retractions 0 to 3 points, air entry 0 to 3 points, cyanosis 0 to 3 points, state of consciousness 0 to 3 points) at 30 and 120 minutes<BR/>Respiratory rate<BR/>Heart rate<BR/>Length of stay<BR/>Additional treatment<BR/>Betamethasone treatment<BR/>Re-admission</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-12-24 04:03:24 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-12-24 04:03:51 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuusela-1988">
<CHAR_METHODS MODIFIED="2010-03-15 08:53:14 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized, double-blind, placebo-controlled trial<BR/>78 children were enrolled and 72 were treated and evaluated by the protocol<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-12-24 04:03:35 +1000" MODIFIED_BY="[Empty name]">
<P>78 children admitted with moderate croup (70 children's symptoms were consistent with spasmodic croup). All children were placed in a humid room</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-24 03:29:13 +1000" MODIFIED_BY="[Empty name]">
<P>0.25 mL per 5 kg body weight of 2.25% solution of nebulized racemic epinephrine (containing 2.5 mg L-epinephrine) (n = 16) or placebo (n = 21) via IPPB<BR/>Nebulization was repeated at 2 hours</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-12-24 04:03:51 +1000" MODIFIED_BY="[Empty name]">
<P>Dyspnea score (0 to 3 points)<BR/>Cough score (0 to 3 points) at 6, 12, 24 and 48 hours<BR/>Length of stay<BR/>pH day 1<BR/>PCO<SUB>2</SUB> day 1<BR/>Base deficit</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-03-16 08:06:29 +1000" MODIFIED_BY="[Empty name]">
<P>PCO<SUB>2</SUB>: partial pressure of carbon dioxide</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-26 19:49:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Waisman-1992">
<CHAR_METHODS MODIFIED="2010-03-15 08:53:34 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized, double-blind controlled trial<BR/>3 children were withdrawn</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-26 19:49:57 +1000" MODIFIED_BY="[Empty name]">
<P>66 children hospitalized due to symptoms suggestive of moderate croup (spasmodic croup was excluded). All children were received mist therapy prior to randomization<BR/>Croup suggestive symptoms: acute laryngitis, laryngotracheobronchitis and laryngitis with stridor</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-24 03:29:17 +1000" MODIFIED_BY="[Empty name]">
<P>2.25% racemic epinephrine (n = 16) or 5 mL of 1:1000 L-epinephrine (n = 15) (each containing 5 mg L-epinephrine and delivered via nebulization alone)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-12-24 04:04:22 +1000" MODIFIED_BY="[Empty name]">
<P>Croup score (10 points: inspiratory breath sounds 0 to 2 points, stridor 0 to 2 points, cough 0 to 2 points, retractions/nasal flaring 0 to 2 points, cyanosis 0 to 2 points) at 5, 15, 30, 60, 90 and 120 minutes<BR/>Respiratory rate<BR/>Dexamethasone treatment<BR/>Supplemental oxygen<BR/>Intubation<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-12-24 04:04:34 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-12-24 04:05:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Westley-1978">
<CHAR_METHODS MODIFIED="2010-03-15 08:53:47 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized, double-blind, placebo-controlled trial<BR/>3 children were withdrawn due to mechanical failure in the IPPB machine</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-12-24 04:05:05 +1000" MODIFIED_BY="[Empty name]">
<P>23 children admitted with moderate croup and inspiratory stridor after 15 to 30 minutes in a humidity mist room (unclear if spasmodic croup was excluded). All children received continuous room temperature mist and no supplemental oxygen was given except during IPPB treatment and 4 children received antibiotics</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-24 03:29:20 +1000" MODIFIED_BY="[Empty name]">
<P>0.5 mL of 2.25% racemic epinephrine (containing 5 mg L-epinephrine) (n = 10) or nebulized saline with IPPB (n = 10)<BR/>IPPB pressure was 10 cm and increased to 15 cm within the first minute</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-10-27 03:18:24 +1000" MODIFIED_BY="[Empty name]">
<P>Westley croup score (17 points: level of consciousness 0 to 5 points, cyanosis 0 to 5 points, stridor 0 to 2 points, air entry 0 to 2 points, retractions 0 to 3 points) at 10, 30, and 120 minutes<BR/>Pulse<BR/>Respiratory rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-12-24 04:05:15 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ED = emergency department<BR/>IM = intramuscular<BR/>IPPB = intermittent positive pressure breathing<BR/>PCO<SUB>2</SUB> = partial pressure of carbon dioxide</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-08-26 19:52:08 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Anonymous-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:26 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-15 08:53:59 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Banac-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-15 08:53:59 +1000" MODIFIED_BY="[Empty name]">
<P>There is no comparison group. All children were treated with L-epinephrine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bass-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:27 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bass-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:27 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Beaudry-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:28 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brown-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:28 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:29 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Celis-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:29 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:29 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cherry-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:29 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-26 19:51:45 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Choi-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-26 19:51:45 +1000" MODIFIED_BY="[Empty name]">
<P>Children were randomized to L-epinephrine or nebulized budesonide</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:29 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cressman-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:29 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cristaldi-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:30 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cronin-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:30 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-25 07:06:43 +1000" MODIFIED_BY="Candice Bjornson" STUDY_ID="STD-da-Silva-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-25 07:06:43 +1000" MODIFIED_BY="Candice Bjornson">
<P>Compares 3 doses of epinephrine in children with post-extubation stridor</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-25 07:07:18 +1000" MODIFIED_BY="Candice Bjornson" STUDY_ID="STD-Danen-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-25 07:07:18 +1000" MODIFIED_BY="Candice Bjornson">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dardick-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:31 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-25 07:07:45 +1000" MODIFIED_BY="Candice Bjornson" STUDY_ID="STD-de-Benedictis-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-25 07:07:45 +1000" MODIFIED_BY="Candice Bjornson">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-15 08:54:07 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dunman-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-15 08:54:07 +1000" MODIFIED_BY="[Empty name]">
<P>Compares cool mist and intramuscular dexamethasone versus nebulized L-epinephrine and intramuscular dexamethasone versus nebulized L-epinephrine and nebulized budesonide</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ellis-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:31 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-15 08:54:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fitzgerald-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-15 08:54:09 +1000" MODIFIED_BY="[Empty name]">
<P>Compares L-epinephrine versus budesonide</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:32 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fogel-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:32 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-25 07:07:53 +1000" MODIFIED_BY="Candice Bjornson" STUDY_ID="STD-Frazier-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-25 07:07:53 +1000" MODIFIED_BY="Candice Bjornson">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:34 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghosh-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:34 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:34 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gilligan-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:34 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:35 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gonzalez-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:35 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:35 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heisinge-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:35 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:36 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jones-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:36 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Klassen-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:37 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-25 07:08:03 +1000" MODIFIED_BY="Candice Bjornson" STUDY_ID="STD-Kline_x002d_Krammes-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-25 07:08:03 +1000" MODIFIED_BY="Candice Bjornson">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Koren-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:37 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:38 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kunkel-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:38 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ledwith-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:39 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lenney-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:39 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:42 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Loriette-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:42 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Niggermann-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:43 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Osmond-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:43 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-25 07:08:10 +1000" MODIFIED_BY="Candice Bjornson" STUDY_ID="STD-Pitluk-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-25 07:08:10 +1000" MODIFIED_BY="Candice Bjornson">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:08:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Preutthipan-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:08:28 +1000" MODIFIED_BY="[Empty name]">
<P>Compares 2 doses of epinephrine in children with post-intubation croup</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Remington-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:44 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:45 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rygnestad-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:45 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:45 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Singer-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:45 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:46 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Skolnik-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:46 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-15 08:54:14 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Steele-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-15 08:54:14 +1000" MODIFIED_BY="[Empty name]">
<P>Compares children with croup to healthy controls</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-26 19:52:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taussig-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-26 19:52:03 +1000" MODIFIED_BY="[Empty name]">
<P>All children received mist therapy and were randomized to epinephrine or no treatment (no placebo administered)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taussig-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:47 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thomas-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:48 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thompson-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:48 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-25 07:08:20 +1000" MODIFIED_BY="Candice Bjornson" STUDY_ID="STD-Vorwerk-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-25 07:08:20 +1000" MODIFIED_BY="Candice Bjornson">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-15 08:54:18 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weber-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-15 08:54:18 +1000" MODIFIED_BY="[Empty name]">
<P>Compared epinephrine to heliox</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 04:06:49 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zach-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 04:06:49 +1000" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-25 07:08:25 +1000" MODIFIED_BY="Candice Bjornson" STUDY_ID="STD-Zoorob-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-25 07:08:25 +1000" MODIFIED_BY="Candice Bjornson">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT = randomized controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-08-26 19:47:45 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:25:20 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Corkey-1981">
<DESCRIPTION>
<P>Random numbers table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 08:58:10 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fernandez-1993">
<DESCRIPTION>
<P>Details not reported </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-26 19:47:45 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fogel-1982">
<DESCRIPTION>
<P>Details not reported - prospectively randomized</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:21:04 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gardner-1973">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:18:03 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kristjansson-1994">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:16:34 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuusela-1988">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:09:00 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waisman-1992">
<DESCRIPTION>
<P>Table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:12:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westley-1978">
<DESCRIPTION>
<P>Table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:25:37 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Corkey-1981">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-26 19:46:36 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandez-1993">
<DESCRIPTION>
<P>Vials were pre-numbered and labeled by the pharmacy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:23:28 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fogel-1982">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gardner-1973">
<DESCRIPTION>
<P>Used numbered vials but did not describe how they were allocated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:18:09 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kristjansson-1994">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:16:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kuusela-1988">
<DESCRIPTION>
<P>Sequentially numbered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-26 19:50:10 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waisman-1992">
<DESCRIPTION>
<P>Pharmacy-controlled randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:12:19 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westley-1978">
<DESCRIPTION>
<P>Prepared identical bottles</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-03-16 09:25:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Corkey-1981">
<DESCRIPTION>
<P>Nurse was the only one who knew study drug</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-03-16 09:56:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandez-1993">
<DESCRIPTION>
<P>Nurses were not told which vial was used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fogel-1982">
<DESCRIPTION>
<P>Patient and evaluator did not know</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-03-16 09:21:35 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gardner-1973">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-03-16 09:18:14 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kristjansson-1994">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-03-16 09:16:47 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuusela-1988">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-24 03:29:25 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waisman-1992">
<DESCRIPTION>
<P>Identical vials blinded to patient and investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-03-16 09:12:48 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westley-1978">
<DESCRIPTION>
<P>Identical bottles and code unknown to investigators</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="Candice Bjornson" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-21 07:32:02 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Corkey-1981">
<DESCRIPTION>
<P>Nurse was the only one who knew study drug</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Fernandez-1993">
<DESCRIPTION>
<P>Vial were pre-numbered and labeled by the pharmacy; treating personnel did not know which study treatment was used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-07-02 11:25:48 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Fogel-1982">
<DESCRIPTION>
<P>Patient and evaluator did not know. The respiratory therapist was the only person who knew which study group the participant was in. The delivery of the study intervention was via the same apparatus in both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Gardner-1973">
<DESCRIPTION>
<P>Authors reported that placebo and racemic epinephrine solutions were indistinguishable by smell or appearance </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Kristjansson-1994">
<DESCRIPTION>
<P>Authors reported that placebo and racemic epinephrine solutions were indistinguishable by smell and solubility </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Kuusela-1988">
<DESCRIPTION>
<P>Authors reported that placebo and racemic epinephrine solutions were indistinguishable by smell or appearance and were identically packaged </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Waisman-1992">
<DESCRIPTION>
<P>Identical vials blinded to participant and personnel</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Westley-1978">
<DESCRIPTION>
<P>Identical bottles and code unknown to investigators or participants</P>
<P>Racemic epinephrine and placebo reported to be identical in smell</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2013-07-02 11:26:21 +1000" MODIFIED_BY="Candice Bjornson" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-07-02 11:26:21 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Corkey-1981">
<DESCRIPTION>
<P>Nurse was the only one who knew study drug. Outcome assessors were unable to distinguish treatment solutions on basis of smell or other characteristics</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-21 07:32:02 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Fernandez-1993">
<DESCRIPTION>
<P>Details not reported, but assessors would not know which study treatment vial was used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Fogel-1982">
<DESCRIPTION>
<P>The evaluator did not know</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="UNKNOWN" STUDY_ID="STD-Gardner-1973">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="UNKNOWN" STUDY_ID="STD-Kristjansson-1994">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-21 07:32:03 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Kuusela-1988">
<DESCRIPTION>
<P>Code was not available to investigators until end of study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-07-02 11:24:58 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Waisman-1992">
<DESCRIPTION>
<P>Drug code broken only after the last participant completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-07-02 11:24:06 +1000" MODIFIED_BY="Candice Bjornson" RESULT="YES" STUDY_ID="STD-Westley-1978">
<DESCRIPTION>
<P>Evaluators of outcome were not aware of which intervention the participant had received at time of evaluation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-16 09:26:11 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Corkey-1981">
<DESCRIPTION>
<P>No missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-16 08:59:37 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fernandez-1993">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-16 09:24:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fogel-1982">
<DESCRIPTION>
<P>Data were complete</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-03-16 09:21:54 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gardner-1973">
<DESCRIPTION>
<P>Pre-selected outcomes are not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kristjansson-1994">
<DESCRIPTION>
<P>5 additional patients were not included because protocols were incomplete - details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-26 20:09:44 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Kuusela-1988">
<DESCRIPTION>
<P>6 patients not analyzed but details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-07-02 11:24:53 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waisman-1992">
<DESCRIPTION>
<P>3 participants were not included because of intubation (n = 2) and tracheal stenosis (n = 1)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-07-02 11:24:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westley-1978">
<DESCRIPTION>
<P>Missing data for 3 participants because IPPB machine broke</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-08-26 19:48:02 +1000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:26:26 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Corkey-1981">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-08 10:39:18 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fernandez-1993">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-26 19:48:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fogel-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:20:16 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gardner-1973">
<DESCRIPTION>
<P>Methods do not include sufficient details to adequately assess</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:19:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kristjansson-1994">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:17:13 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuusela-1988">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:11:14 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Waisman-1992">
<DESCRIPTION>
<P>Primary outcome not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:14:51 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Westley-1978">
<DESCRIPTION>
<P>Details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-12-28 14:31:18 +1000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-28 14:29:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Corkey-1981">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-24 04:01:41 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fernandez-1993">
<DESCRIPTION>
<P>Authors measured croup score in 6-hour intervals and measurements were treated separately instead of as repeated measures</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:22:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fogel-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-28 14:31:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gardner-1973">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 08:54:58 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristjansson-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-28 14:31:18 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kuusela-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:08:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Waisman-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-16 09:11:45 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westley-1978">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-06-21 07:39:18 +1000" MODIFIED_BY="Candice Bjornson"/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Nebulized epinephrine versus placebo</NAME>
<CONT_OUTCOME CHI2="0.3820254374483699" CI_END="-0.5095955829037933" CI_START="-1.3694877097445304" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.9395416463241618" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2011-01-12 07:38:30 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8261221381528404" P_Q="0.6279749129646708" P_Z="1.8437320557056475E-5" Q="0.23481697680547375" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="45" TOTAL_2="49" UNITS="" WEIGHT="100.0" Z="4.283020465686599">
<NAME>Croup score (change baseline - 30 minutes)</NAME>
<GROUP_LABEL_1>Epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours epinephrine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.14720846064289617" CI_END="-0.16629332992004886" CI_START="-1.470388694349638" DF="1" EFFECT_SIZE="-0.8183410121348434" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.01" NO="1" P_CHI2="0.701217598886332" P_Z="0.013900731893711257" STUDIES="2" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="43.477968426865985" Z="2.4598184375233973">
<NAME>Inpatient</NAME>
<CONT_DATA CI_END="-0.01376035206767423" CI_START="-1.8858548238084145" EFFECT_SIZE="-0.9498075879380443" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-0.1" ORDER="86159" SD_1="2.06" SD_2="1.76" SE="0.4775838960581884" STUDY_ID="STD-Corkey-1981" TOTAL_1="10" TOTAL_2="10" WEIGHT="21.09756936891921"/>
<CONT_DATA CI_END="0.21441456528952285" CI_START="-1.6032345925035805" EFFECT_SIZE="-0.6944100136070288" ESTIMABLE="YES" MEAN_1="-2.2" MEAN_2="-1.0" ORDER="86160" SD_1="1.64" SD_2="1.67" SE="0.4636945301369025" STUDY_ID="STD-Westley-1978" TOTAL_1="10" TOTAL_2="10" WEIGHT="22.38039905794677"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.4608915480222625" CI_START="-1.6046520398396544" DF="0" EFFECT_SIZE="-1.0327717939309584" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" NO="2" P_CHI2="1.0" P_Z="4.0081834420459137E-4" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="29" WEIGHT="56.52203157313402" Z="3.539544397336424">
<NAME>Outpatient</NAME>
<CONT_DATA CI_END="-0.4608915480222625" CI_START="-1.6046520398396544" EFFECT_SIZE="-1.0327717939309584" ESTIMABLE="YES" MEAN_1="-2.7" MEAN_2="-1.1" ORDER="86161" SD_1="1.88" SD_2="1.14" SE="0.2917809972119969" STUDY_ID="STD-Kristjansson-1994" TOTAL_1="25" TOTAL_2="29" WEIGHT="56.52203157313402"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2013-06-01 06:39:14 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Croup score (change baseline - 2 hours)</NAME>
<GROUP_LABEL_1>Epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours epinephrine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
<CONT_DATA CI_END="0.729510918018824" CI_START="-1.0265411149176762" EFFECT_SIZE="-0.1485150984494261" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.3" ORDER="86169" SD_1="1.64" SD_2="2.19" SE="0.44798068913204897" STUDY_ID="STD-Westley-1978" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.678582315128134" CI_END="-0.08298812203610373" CI_START="-1.1232870473766696" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6031375847063867" ESTIMABLE="YES" I2="55.08028712613925" I2_Q="40.10724965601629" ID="CMP-001.03" MODIFIED="2010-12-28 12:00:19 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.08287959590701166" P_Q="0.18831295687524874" P_Z="0.02304608953297733" Q="3.339302317080689" RANDOM="YES" SCALE="2.5" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.15517260803410782" TOTALS="YES" TOTAL_1="62" TOTAL_2="76" UNITS="" WEIGHT="100.0" Z="2.2726697393443858">
<NAME>Croup score (change baseline - 6 hours)</NAME>
<GROUP_LABEL_1>Epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours epinephrine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.339291157564067" CI_END="0.29741994094608415" CI_START="-1.5044434129023925" DF="1" EFFECT_SIZE="-0.6035117359781541" ESTIMABLE="YES" I2="70.0535247507595" ID="CMP-001.03.01" NO="1" P_CHI2="0.0676438201282783" P_Z="0.18920614773764874" STUDIES="2" TAU2="0.29603882401711623" TOTAL_1="31" TOTAL_2="38" WEIGHT="50.0" Z="1.3129311545606783">
<NAME>Inpatient</NAME>
<CONT_DATA CI_END="0.5507471931503637" CI_START="-0.8399310727068799" EFFECT_SIZE="-0.14459193977825816" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-2.2" ORDER="86162" SD_1="1.5" SD_2="1.2" SE="0.3547713827465036" STUDY_ID="STD-Fernandez-1993" TOTAL_1="15" TOTAL_2="17" WEIGHT="25.061045650095025"/>
<CONT_DATA CI_END="-0.36479881850969265" CI_START="-1.763057358587942" EFFECT_SIZE="-1.0639280885488174" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.5" ORDER="86163" SD_1="0.4" SD_2="0.5" SE="0.3567051617038717" STUDY_ID="STD-Kuusela-1988" TOTAL_1="16" TOTAL_2="21" WEIGHT="24.938954349904975"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.36479881850969265" CI_START="-1.763057358587942" DF="0" EFFECT_SIZE="-1.0639280885488174" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.03" MODIFIED="2010-10-27 05:31:45 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.002857608155359912" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="21" WEIGHT="24.938954349904975" Z="2.982654031320314">
<NAME>IPPB administration</NAME>
<CONT_DATA CI_END="-0.36479881850969265" CI_START="-1.763057358587942" EFFECT_SIZE="-1.0639280885488174" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.5" MODIFIED="2010-10-27 05:31:45 +1000" MODIFIED_BY="[Empty name]" ORDER="26" SD_1="0.4" SD_2="0.5" SE="0.3567051617038717" STUDY_ID="STD-Kuusela-1988" TOTAL_1="16" TOTAL_2="21" WEIGHT="24.938954349904975"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5507471931503637" CI_START="-0.8399310727068799" DF="0" EFFECT_SIZE="-0.14459193977825816" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.04" MODIFIED="2010-10-27 05:31:38 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.6835940151095139" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="17" WEIGHT="25.061045650095025" Z="0.407563706685931">
<NAME>No IPPB administration</NAME>
<CONT_DATA CI_END="0.5507471931503637" CI_START="-0.8399310727068799" EFFECT_SIZE="-0.14459193977825816" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-2.2" MODIFIED="2010-10-27 05:31:38 +1000" MODIFIED_BY="[Empty name]" ORDER="25" SD_1="1.5" SD_2="1.2" SE="0.3547713827465036" STUDY_ID="STD-Fernandez-1993" TOTAL_1="15" TOTAL_2="17" WEIGHT="25.061045650095025"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="41" TOTAL_2="50" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of hospitalization in hours</NAME>
<GROUP_LABEL_1>Epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours epinephrine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
<CONT_DATA CI_END="-4.859418543788426" CI_START="-59.14058145621158" EFFECT_SIZE="-32.0" ESTIMABLE="YES" MEAN_1="59.0" MEAN_2="91.0" ORDER="86165" SD_1="43.0" SD_2="40.0" SE="13.847489887718865" STUDY_ID="STD-Kuusela-1988" TOTAL_1="16" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
<CONT_DATA CI_END="0.4708323312402771" CI_START="-4.070832331240279" EFFECT_SIZE="-1.8000000000000007" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="13.3" ORDER="86166" SD_1="4.07" SD_2="4.44" SE="1.1586092138183728" STUDY_ID="STD-Kristjansson-1994" TOTAL_1="25" TOTAL_2="29" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RD" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="25" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>Return visits and/or (re)admissions</NAME>
<GROUP_LABEL_1>Epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours epinephrine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
<DICH_DATA CI_END="0.06989456155840966" CI_START="-0.06989456155840966" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="86164" O_E="0.0" SE="0.03566114587294922" STUDY_ID="STD-Kristjansson-1994" TOTAL_1="25" TOTAL_2="29" VAR="0.001271717324971763" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1983824123704554" CI_END="2.599319468685465" CI_START="0.8172133513968083" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.457463061060355" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="13" I2="16.554182564983233" I2_Q="15.584637254196512" ID="CMP-001.06" LOG_CI_END="0.4148596596321295" LOG_CI_START="-0.08766454660323089" LOG_EFFECT_SIZE="0.16359755651444932" METHOD="MH" MODIFIED="2013-10-03 08:03:55 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.2736452849576464" P_Q="0.2764178210321675" P_Z="0.20190648366225428" Q="1.184618495345757" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.030683884177034788" TOTALS="YES" TOTAL_1="39" TOTAL_2="35" WEIGHT="100.0" Z="1.2761387998766391">
<NAME>Improvement</NAME>
<GROUP_LABEL_1>Epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ephinephrine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.5023967574949797" CI_START="0.958156716265061" DF="0" EFFECT_SIZE="1.831896551724138" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="8" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.5443653421559346" LOG_CI_START="-0.018563451837110837" LOG_EFFECT_SIZE="0.26290094515941187" MODIFIED="2010-12-24 04:43:44 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.06714559179321125" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="25" WEIGHT="62.2278312522805" Z="1.830698267746997">
<NAME>Outpatient</NAME>
<DICH_DATA CI_END="3.5023967574949797" CI_START="0.958156716265061" EFFECT_SIZE="1.831896551724138" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="8" LOG_CI_END="0.5443653421559346" LOG_CI_START="-0.018563451837110837" LOG_EFFECT_SIZE="0.26290094515941187" ORDER="86167" O_E="0.0" SE="0.33066716013398584" STUDY_ID="STD-Kristjansson-1994" TOTAL_1="29" TOTAL_2="25" VAR="0.10934077079107504" WEIGHT="62.2278312522805"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.402530460804138" CI_START="0.41622781326372665" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" ID="CMP-001.06.03" LOG_CI_END="0.38066890263622855" LOG_CI_START="-0.3806689026362286" LOG_EFFECT_SIZE="0.0" NO="3" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="37.7721687477195" Z="0.0">
<NAME>Setting not reported</NAME>
<DICH_DATA CI_END="2.402530460804138" CI_START="0.41622781326372665" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.38066890263622855" LOG_CI_START="-0.3806689026362286" LOG_EFFECT_SIZE="0.0" ORDER="86168" O_E="0.0" SE="0.447213595499958" STUDY_ID="STD-Gardner-1973" TOTAL_1="10" TOTAL_2="10" VAR="0.20000000000000004" WEIGHT="37.7721687477195"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-10-02 06:19:49 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Nebulized racemic epinephrine versus L-epinephrine</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2013-06-01 06:42:04 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Croup score (change baseline - 30 minutes)</NAME>
<GROUP_LABEL_1>Racemic epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>L-epinephrine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours racemic epi</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours L-epi</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
<CONT_DATA CI_END="1.0754613192913414" CI_START="-0.41774121107314727" EFFECT_SIZE="0.3288600541090971" ESTIMABLE="YES" MEAN_1="-2.28" MEAN_2="-2.84" ORDER="86170" SD_1="1.39" SD_2="1.88" SE="0.3809260124529531" STUDY_ID="STD-Waisman-1992" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2013-06-01 06:42:38 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Croup score (change baseline - 2 hours)</NAME>
<GROUP_LABEL_1>Racemic epinephine</GROUP_LABEL_1>
<GROUP_LABEL_2>L-epinephrine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours racemic epi</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours L-epi</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
<CONT_DATA CI_END="1.649578113529783" CI_START="0.08870103145864239" EFFECT_SIZE="0.8691395724942126" ESTIMABLE="YES" MEAN_1="-0.65" MEAN_2="-2.2" ORDER="86171" SD_1="1.19" SD_2="2.14" SE="0.3981902459389916" STUDY_ID="STD-Waisman-1992" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RD" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-06-01 06:42:53 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="16" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Intubation</NAME>
<GROUP_LABEL_1>Racemic epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>L-epiephrine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours racemic- epi</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours L-epi</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
<DICH_DATA CI_END="0.40009502565946875" CI_START="-0.025095025659468723" EFFECT_SIZE="0.1875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="86172" O_E="0.0" SE="0.10846884296670303" STUDY_ID="STD-Waisman-1992" TOTAL_1="16" TOTAL_2="14" VAR="0.011765489894535283" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-10-02 06:20:25 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Nebulized epinephrine with IPPB versus nebulized epinephrine without IPPB</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2013-06-01 06:43:41 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="9" TOTAL_2="5" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Croup score (change baseline - 30 minutes)</NAME>
<GROUP_LABEL_1>IPPB epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>No IPPB epinephrine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IPPB epi</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no IPPB epi</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
<CONT_DATA CI_END="0.9500552076516628" CI_START="-1.2400447729111823" EFFECT_SIZE="-0.14499478262975976" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-3.3" ORDER="86173" SD_1="2.26" SD_2="1.02" SE="0.5587092410467933" STUDY_ID="STD-Fogel-1982" TOTAL_1="9" TOTAL_2="5" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2013-06-01 06:44:59 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="9" TOTAL_2="5" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Croup score (change baseline - 2 hours)</NAME>
<GROUP_LABEL_1>IPPB epinephine</GROUP_LABEL_1>
<GROUP_LABEL_2>No IPPB epinephrine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IPPB epi</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no IPPB epi</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
<CONT_DATA CI_END="0.4150087424362795" CI_START="-1.8608686348832335" EFFECT_SIZE="-0.722929946223477" ESTIMABLE="YES" MEAN_1="-1.2" MEAN_2="0.2" ORDER="86174" SD_1="2.1" SD_2="1.02" SE="0.5805916321094018" STUDY_ID="STD-Fogel-1982" TOTAL_1="9" TOTAL_2="5" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RD" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-06-01 06:45:09 +1000" MODIFIED_BY="Candice Bjornson" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="5" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Intubation</NAME>
<GROUP_LABEL_1>Epinephrine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IPPB</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no IPPB</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient</NAME>
<DICH_DATA CI_END="0.2591416431912055" CI_START="-0.2591416431912055" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="86175" O_E="0.0" SE="0.13221755360572016" STUDY_ID="STD-Fogel-1982" TOTAL_1="5" TOTAL_2="9" VAR="0.01748148148148148" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-08-26 20:09:46 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-08-26 20:09:46 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEZCAMAAABxStv9AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-08-26 20:09:46 +1000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAW4AAAJFCAIAAAByQ4qwAAAgSklEQVR42u3dv44USdbG4ZKQEAYG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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-06-20 05:58:53 +1000" MODIFIED_BY="Liz Dooley">
<APPENDIX ID="APP-01" MODIFIED="2010-12-24 04:19:35 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-12-24 04:19:35 +1000" MODIFIED_BY="[Empty name]">Glossary of terms</TITLE>
<APPENDIX_BODY MODIFIED="2010-12-24 04:18:19 +1000" MODIFIED_BY="[Empty name]">
<P>Rhinorrhea - runny nose.</P>
<P>Stridor - noisy breathing heard on inspiration.</P>
<P>Nebulized epinephrine alone - epinephrine delivered by inhalation with a mask, a holding chamber for the medication, and attached tube through which oxygen flows. The flow of oxygen through the liquid medication creates droplets which are then breathed in by the child.</P>
<P>Nebulized epinephrine delivered with intermittent positive pressure breathing (IPPB) - epinephrine delivered via nebulizer under intermittent pressure.</P>
<P>Intubation - the placement of a breathing tube in children with severe breathing difficulties.</P>
<P>Pulsus paradoxus - an exaggeration of the normal variation in the pulse during respiration, in which the pulse becomes weaker as one inhales and stronger as one exhales.</P>
<P>Impedance plesmography - a technique for measuring paradoxical breathing. This type of breathing occurs in young children with severe respiratory distress. Typically, in well people the abdomen and chest expand and contract in a synchronized fashion with respiration. Children compensate for narrowing of their upper airway by increasing their work of breathing, which increases intrapleural pressure and the rate of airflow through the upper airway. With greater increases in pleural pressure, during inspiration, young children's compliant chest wall begins to collapse as the abdomen protrudes, owing to diaphragmatic contraction. The severity of paradoxical breathing can be measured using a device called respiratory inductance plethysmograph, which measures the phase angle. A decrease in phase angle equates to a reduction in the severity of paradoxical breathing.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-01-24 11:07:33 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-01-24 11:07:33 +1000" MODIFIED_BY="[Empty name]">EMBASE.com search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-01-24 11:06:57 +1000" MODIFIED_BY="[Empty name]">
<P>#18 #14 AND #176815 Nov 2010<BR/>#17 #15 OR #1682006715 Nov 2010<BR/>#16 random*:ab,ti OR placebo*:ab,ti OR factorial*:ab,ti OR crossover*:ab,ti OR 'cross over':ab,ti OR 'cross-over':ab,ti OR assign*:ab,ti OR allocat*:ab,ti OR volunteer*:ab,ti OR ((singl* OR doubl*) NEAR/2 (blind* OR mask*)):ab,ti <BR/>#15 'randomized controlled trial'/exp OR 'single blind procedure'/exp OR 'double blind procedure'/exp OR 'crossover procedure'/exp <BR/>#14 #3 AND #9 AND #13 <BR/>#13 #10 OR #11 OR #12 <BR/>#12 'positive- pressure breathing':ab,ti OR 'positive-pressure respiration':ab,ti OR ippb:ab,ti <BR/>#11 inhal*:ab,ti OR vapor*:ab,ti OR vapour*:ab,ti OR atomiz*:ab,ti OR atomis*:ab,ti OR nebuliz*:ab,ti OR nebulis*:ab,ti OR spray*:ab,ti OR mist*:ab,ti OR aerosol*:ab,ti <BR/>#10 'nebulizer'/exp OR 'aerosol'/de OR 'artificial ventilation'/de OR 'intermittent positive pressure ventilation'/de OR 'positive end expiratory pressure'/exp OR 'oxygen therapy'/de <BR/>#9 #4 OR #5 OR #6 OR #7 OR #8 <BR/>#8 'adrenal cortex hormone':ab,ti OR 'adrenal cortex hormones':ab,ti OR '17-ketosteroid':ab,ti OR '17-ketosteroids':ab,ti OR 'hydroxycorticosteroid':ab,ti OR 'hydroxycorticosteroids':ab,ti <BR/>#7 'corticosteroid'/exp OR '17 oxosteroid'/de <BR/>#6 adrenalin*:ab,ti OR 'l-adrenalin':ab,ti OR 'l-adrenaline':ab,ti OR epinephrin*:ab,ti OR 'adrenergic agonist':ab,ti OR 'adrenergic agonists':ab,ti OR 'adrenergic alpha-agonist':ab,ti OR 'adrenergic alpha-agonists':ab,ti OR 'adrenergic beta-agonist':ab,ti OR 'adrenergic beta-agonists':ab,ti <BR/>#5 'adrenergic receptor stimulating agent'/exp <BR/>#4 'adrenalin'/de <BR/>#3 #1 OR #2 <BR/>#2 laryngit*:ab,ti OR croup:ab,ti OR laryngotracheobronchit*:ab,ti OR 'laryngo-tracheo-bronchitis':ab,ti OR laryngotracheit*:ab,ti OR pseudocroup:ab,ti OR 'pseudo-croup':ab,ti <BR/>#1 'laryngitis'/de OR 'croup'/de OR 'laryngotracheobronchitis'/de OR 'pseudocroup'/de </P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2011-01-20 09:11:20 +1000" MODIFIED_BY="Liz Dooley" NO="3">
<TITLE MODIFIED="2010-12-24 04:20:03 +1000" MODIFIED_BY="[Empty name]">CINAHL search (EBSCO)</TITLE>
<APPENDIX_BODY MODIFIED="2011-01-20 09:11:20 +1000" MODIFIED_BY="Liz Dooley">
<P>S15 S4 and S13<BR/>S14 S4 and S13<BR/>S13 S9 and S12<BR/>S12 S10 or S11<BR/>S11 TI (inhal* or vapor* or vapour* or atomiz* or atomis* or nebuliz* or nebulis* or spray* or mist* or aerosol*) or AB (inhal* or vapor* or vapour* or atomiz* or atomis* or nebuliz* or nebulis* or spray* or mist* or aerosol*)<BR/>S10 (MH "Nebulizers and Vaporizers")<BR/>S9 S5 or S6 or S7 or S8<BR/>S8 TI (epinephrine or adrenaline or adrenergic agonist*) or AB (epinephrine or adrenaline or adrenergic agonist*)<BR/>S7 (MH "Adrenal Cortex Hormones")<BR/>S6 (MH "Adrenergic Agonists")<BR/>S5 (MH "Epinephrine+")<BR/>S4 S1 or S2 or S3<BR/>S3 TI (laryngotracheobronchit* or laryngotracheit* or pseudocroup or psuedo-croup) or AB (laryngotracheobronchit* or laryngotracheit* or pseudocroup or psuedo-croup)<BR/>S2 TI croup or AB croup<BR/>S1 (MH "Laryngitis+")<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2013-01-24 11:07:54 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2013-01-24 11:07:54 +1000" MODIFIED_BY="[Empty name]">Web of Science search strategy (Thomson Reuters)</TITLE>
<APPENDIX_BODY MODIFIED="2013-01-24 10:57:11 +1000" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="6">
<TR>
<TD VALIGN="TOP">
<P># 6</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=6&amp;SID=R1Fj5@MKO72LjFKkIE9&amp;search_mode=CombineSearches">67</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>#5 AND #4</P>
<P>
<I>Databases=SCI-EXPANDED, SSCI, A&amp;HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All Years</I>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P># 5</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=5&amp;SID=R1Fj5@MKO72LjFKkIE9&amp;search_mode=GeneralSearch">1,410,273</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Topic=(random* or placebo* or allocat* or crossover* or "cross over" or ((singl* or doubl*) NEAR/1 blind*)) OR Title=(trial)</P>
<P>
<I>Databases=SCI-EXPANDED, SSCI, A&amp;HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All Years</I>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P># 4</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=4&amp;SID=R1Fj5@MKO72LjFKkIE9&amp;search_mode=CombineSearches">112</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>#3 AND #2 AND #1</P>
<P>
<I>Databases=SCI-EXPANDED, SSCI, A&amp;HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All Years</I>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P># 3</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=3&amp;SID=R1Fj5@MKO72LjFKkIE9&amp;search_mode=GeneralSearch">583,070</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Topic=(nebuli* or vapor* or vapour* or inhal* or atomis* or atomiz* or spray* or mist* or aerosol* or (positive-pressure NEAR/3 (breathing or respiration)) or ippb)</P>
<P>
<I>Databases=SCI-EXPANDED, SSCI, A&amp;HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All Years</I>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P># 2</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=2&amp;SID=R1Fj5@MKO72LjFKkIE9&amp;search_mode=GeneralSearch">44,458</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Topic=(epinephrin* or adrenalin* or (adrenergic* NEAR/2 agonist*) or "adrenal cortex hormone" or "adrenal cortex hormones")</P>
<P>
<I>Databases=SCI-EXPANDED, SSCI, A&amp;HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All Years</I>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P># 1</P>
</TD>
<TD VALIGN="TOP">
<P>
<A HREF="http://apps.webofknowledge.com/summary.do?product=WOS&amp;doc=1&amp;qid=1&amp;SID=R1Fj5@MKO72LjFKkIE9&amp;search_mode=GeneralSearch">2,985</A>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Topic=(laryngit* or croup or laryngotracheit* or laryngotracheobronchit* or "laryngo-tracheo-bronchitis" or pseudocroup or "pseudo-croup")</P>
<P>
<I>Databases=SCI-EXPANDED, SSCI, A&amp;HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All Years</I>
</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2013-06-01 04:06:38 +1000" MODIFIED_BY="Liz Dooley" NO="5">
<TITLE MODIFIED="2010-01-27 16:23:13 +1000" MODIFIED_BY="[Empty name]">Scopus search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-06-01 04:06:38 +1000" MODIFIED_BY="Liz Dooley">
<P>((TITLE-ABS-KEY(laryngit* OR croup OR laryngotracheit* OR laryngotracheobronchit* OR "laryngo-tracheo-bronchitis" OR pseudocroup OR "pseudo-croup") AND SUBJAREA(mult OR agri OR bioc OR immu OR neur OR phar OR mult OR medi OR nurs OR vete OR dent OR heal)) AND (TITLE-ABS-KEY(epinephrin* OR adrenalin* OR "adrenergic agonist" OR "adrenergic agonists" OR "adrenal cortex hormone" OR "adrenal cortex hormones") AND SUBJAREA(mult OR agri OR bioc OR immu OR neur OR phar OR mult OR medi OR nurs OR vete OR dent OR heal)) AND (TITLE-ABS-KEY(nebuli* OR vapor* OR vapour* OR inhal* OR atomis* OR atomiz* OR spray* OR mist* OR aerosol* OR ippb OR "positive-pressure breathing" OR "positive-pressure respiration") AND SUBJAREA(mult OR agri OR bioc OR immu OR neur OR phar OR mult OR medi OR nurs OR vete OR dent OR heal))) AND ((TITLE-ABS-KEY(random* OR placebo* OR allocat* OR crossover* OR "cross over" OR (singl* W/1 blind*) OR (doubl* W/1 blind*)) AND SUBJAREA(mult OR agri OR bioc OR immu OR neur OR phar OR mult OR medi OR nurs OR vete OR dent OR heal)) OR (TITLE(trial) AND SUBJAREA(mult OR agri OR bioc OR immu OR neur OR phar OR mult OR medi OR nurs OR vete OR dent OR heal)))</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>